( (TITLE (S (NP-SBJ-1 (NN CARD15) (HYPH /) (NN NOD2)) (VP (VBZ Is) (VP (VBN Required) (NP-1 (-NONE- *)) (PP (IN for) (NP (NML (NP (NNP Peyer) (POS 's)) (NNS Patches)) (NN Homeostasis))) (PP-LOC (IN in) (NP (NNS Mice))))))) )
( (HEADING (NP (NN Abstract))) )
( (HEADING (NP (NN Background))) )
( (S (NP-SBJ-1 (NML (NN CARD15) (HYPH /) (NN NOD2)) (NNS mutations)) (VP (VBP are) (VP (VBN associated) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (NN susceptibility)) (PP (IN to) (NP (NP (NP (NP (NNP Crohn) (POS 's)) (NN Disease)) (-LRB- -LRB-) (NP (NN CD))) (-RRB- -RRB-) (CC and) (NP (NP (NML (NN Graft) (CC Versus) (NN Host)) (NN Disease)) (-LRB- -LRB-) (NP (NN GVHD))))))))) (-RRB- -RRB-) (. .)) )
( (S (NP-SBJ-1 (NN CD) (CC and) (NN GVHD)) (VP (VBP are) (VP (VBN suspected) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN related) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (DT the) (NN dysfunction)) (PP (IN of) (NP (NP (NP (NML (NNP Peyer) (POS 's)) (NNS patches)) (-LRB- -LRB-) (NP (NN PP))) (-RRB- -RRB-) (CC and) (NP (VBN isolated) (NML (NML (JJ lymphoid) (NNS follicles)) (-LRB- -LRB-) (NML (NNS LFs)))))))))))))) (-RRB- -RRB-) (. .)) )
( (S (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG Using) (NP (NP (NP (DT a) (JJ new) (NN mouse) (NN model)) (VP (VBN invalidated) (NP (-NONE- *)) (PP (IN for) (NP (NN Card15) (HYPH /) (NN Nod2))))) (-LRB- -LRB-) (NP (NN KO))))) (-RRB- -RRB-) (, ,) (NP-SBJ (PRP we)) (ADVP (RB thus)) (VP (VBD analysed) (NP (NP (DT the) (NN impact)) (PP (IN of) (NP (DT the) (NN gene))) (PP-LOC (IN in) (NP (DT these) (JJ lymphoid) (NNS formations)))) (ADVP (RB together) (PP (IN with) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ experimental) (NN colitis))))))) (. .)) )
( (HEADING (NP (NP (NN Methodology)) (HYPH /) (NP (JJ Principal) (NNS Findings)))) )
( (S (PP-TMP (IN At) (NP (NNS weeks) (NML (CD 4) (, ,) (CD 12) (CC and) (CD 52)))) (, ,) (NP-SBJ (NP (DT the) (NNS numbers)) (PP (IN of) (NP (NNS PPs) (CC and) (NNS LFs)))) (VP (VBD were) (ADJP-PRD (JJR higher)) (PP-LOC (IN in) (NP (NN KO) (NNS mice))) (SBAR-ADV (IN while) (S (NP-SBJ-1 (DT no) (NN difference)) (VP (VBD was) (VP (VBN observed) (NP-1 (-NONE- *)) (PP-TMP (IN at) (NP (NN birth)))))))) (. .)) )
( (S (PP-TMP (IN At) (NP (NNS weeks) (NML (CD 4) (CC and) (CD 12)))) (, ,) (NP-SBJ-1 (NP (DT the) (NML (NML (NN size)) (CC and) (NML (JJ cellular) (NN composition)))) (PP (IN of) (NP (NNS PPs)))) (VP (VBD were) (VP (VBN analysed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (NN flow) (NN cytometry)) (CC and) (NP (NN immunohistochemistry)))))) (. .)) )
( (S (NP-SBJ (NP (NNS PPs)) (PP (IN of) (NP (NN KO) (NNS mice)))) (VP (VBD were) (ADJP-PRD (JJR larger)) (PP (IN with) (NP (NP (DT an) (VBN increased) (NN proportion)) (PP (IN of) (NP (NP (NN M) (NNS cells)) (CC and) (NP (NML (NN CD4) (SYM +)) (NN T) (HYPH -) (NNS cells))))))) (. .)) )
( (S (NP-SBJ-1 (NN KO) (NNS mice)) (VP (VBD were) (ADVP (RB also)) (VP (VBN characterised) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NP (JJR higher) (NNS concentrations)) (PP (IN of) (NP (NN TNFα) (, ,) (NN IFNγ) (, ,) (NN IL12) (CC and) (NN IL4)))) (VP (VBN measured) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NNP ELISA)))))))) (. .)) )
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ-1 (JJ little) (NNS differences)) (VP (VBD were) (VP (VBN found) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NP (DT the) (ADJP (NN PP) (HYPH -) (JJ free)) (NN ileum)) (CC and) (NP (DT the) (NN spleen))) (PP (IN of) (NP (NN KO) (NNS mice))))))) (. .)) )
( (S (PP-MNR (IN By) (NP (NML (VBG Ussing) (NN chamber)) (NNS experiments))) (, ,) (NP-SBJ (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP-SBJ-1 (DT this) (NN PP) (NN phenotype)) (VP (VBZ is) (VP (VBN associated) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (DT an) (NN increased)) (PP (IN of) (NP (CC both) (NP (JJ paracellular) (NN permeability)) (CC and) (NP (UCP (NN yeast) (HYPH /) (JJ bacterial)) (NN translocation))))))))))) (. .)) )
( (S (ADVP (RB Finally)) (, ,) (NP-SBJ (NN KO) (NNS mice)) (VP (VBD were) (ADJP-PRD (RBR more) (JJ susceptible) (PP (IN to) (NP (NP (DT the) (NN colitis)) (VP (VBN induced) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NN TNBS)))))))) (. .)) )
( (HEADING (NP (NNS Conclusions))) )
( (S (NP-SBJ (NML (NN Card15) (HYPH /) (NN Nod2)) (NN deficiency)) (VP (VBZ induces) (NP (NP (NP (DT an) (JJ abnormal) (NML (NN development) (CC and) (NN function))) (PP (IN of) (NP (DT the) (NNS PPs)))) (VP (VBN characterised) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT an) (VBN exaggerated) (JJ immune) (NN response)) (CC and) (NP (DT an) (VBN increased) (NN permeability))))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS observations)) (VP (VBP provide) (NP (NP (DT a) (JJ comprehensive) (NN link)) (PP (IN between) (NP (NP (DT the) (JJ molecular) (NN defect)) (CC and) (NP (NP (DT the) (JJ Human) (ADJP (NP (NN CARD15) (HYPH /) (NN NOD2)) (VBN associated)) (NNS disorders)) (: :) (NP (NN CD) (CC and) (NN GVHD))))))) (. .)) )
( (HEADING (NP (NN Introduction))) )
( (S (NP-SBJ-1 (NP (NP (NN Caspase) (NN Recruitment) (NN Domain) (CD 15)) (-LRB- -LRB-) (NP (NN CARD15))) (-RRB- -RRB-) (VP (ADVP (RB also)) (VBN known) (NP (-NONE- *)) (PP (IN as) (NP (NP (NN Nucleotide) (NN oligomerisation) (NN domain) (CD 2)) (-LRB- -LRB-) (NP (NN NOD2)))))) (-RRB- -RRB-) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (NP (NML (NNP Crohn) (POS 's)) (NN Disease)) (-LRB- -LRB-) (NP (NN CD)) (-RRB- -RRB-) (PRN (-LRB- [) (NP (CD 1)) (-RRB- ])) (, ,) (PRN (-LRB- [) (NP (CD 2)) (-RRB- ]))) (CC and) (NP (NP (NML (NN graft) (CC versus) (NN host)) (NN disease)) (-LRB- -LRB-) (NP (NN GVHD)) (-RRB- -RRB-) (PRN (-LRB- [) (NP (CD 3)) (-RRB- ])) (, ,) (PRN (-LRB- [) (NP (CD 4)) (-RRB- ])))))))) (. .)) )
( (S (NP-SBJ (NN NOD2)) (VP (VBZ belongs) (PP (IN to) (NP (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NNS genes)))) (VP (VBN involved) (NP (-NONE- *)) (PP (IN in) (NP (JJ innate) (NN immunity))) (PRN (-LRB- [) (NP (CD 5)) (-RRB- ])))))) (. .)) )
( (S (NP-SBJ-1 (PRP It)) (VP (MD can) (VP (VB be) (VP (VBN activated) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NNS muropeptides)) (SBAR (WHNP-2 (WDT which)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBP are) (NP-PRD (NP (NNS components)) (PP (IN of) (NP (DT the) (JJ bacterial) (NN cell) (NN wall)))))))))))) (. .)) )
( (S (SBAR-TMP (WHADVP-2 (WRB When)) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN activated) (NP-1 (-NONE- *)) (ADVP-TMP-2 (-NONE- *T*))))) (, ,) (NP-SBJ (NN NOD2)) (VP (VBZ interacts) (PP (IN with) (NP (NP (NN Rick) (HYPH /) (NN Rip2)) (SBAR (WHNP-3 (WDT which)) (S (NP-SBJ-3 (-NONE- *T*)) (PP (IN in) (ADJP (JJ turn))) (VP (VBZ activates) (NP (DT the) (NML (NN NF) (HYPH -) (NN kB)) (NN pathway)) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG resulting) (PP (IN in) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (JJ pro-inflammatory) (NNS cytokines))))))))))))) (. .)) )
( (S (NP-SBJ (NP (NN Half)) (PP (IN of) (NP (NN CD) (NNS patients)))) (VP (VBP have) (NP (QP (CD one) (CC or) (JJR more)) (NN NOD2) (NNS mutations)) (PRN (-LRB- [) (NP (CD 6)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ-1 (NP (DT Some)) (PP (IN of) (NP (DT the) (ADJP (NN CD) (VBN associated)) (NNS mutations)))) (VP (VBD were) (VP (VBN found) (S (NP-SBJ-1 (-NONE- *)) (ADJP-PRD (JJ unresponsive) (PP (IN to) (NP (NNS muropeptides))))) (PRN (-LRB- [) (NP (CD 5)) (-RRB- ])))) (. .)) )
( (S (PP (IN By) (NP (NN consequence))) (, ,) (NP-SBJ-1 (NN CD)) (VP (VBZ is) (ADVP (RB usually)) (VP (VBN considered) (NP-1 (-NONE- *)) (PP (IN as) (NP (NP (DT an) (JJ immune) (NN deficiency)) (PP (IN toward) (NP (NP (NNS bacteria)) (RRC (ADJP-PRD (JJ present)) (PP-LOC (IN in) (NP (DT the) (NN gut) (NN lumen)))))))) (PRN (-LRB- [) (NP (CD 7)) (-RRB- ])))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ (NP (DT the) (JJ exact) (NN mechanism)) (SBAR (WHPP-1 (IN by) (WHNP (WDT which))) (S (NP-SBJ-2 (NN NOD2) (NNS mutations)) (VP (VBP are) (ADJP-PRD (JJ able) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (TO to) (VP (VB induce) (NP (NN CD) (NNS lesions)))))) (PP-MNR-1 (-NONE- *T*)))))) (VP (VBZ is) (ADVP-TMP (RB still)) (ADJP-PRD (JJ subject) (PP (IN to) (NP (NN debate)))) (PRN (-LRB- [) (NP (CD 7)) (-RRB- ]) (PP (SYM –) (-LRB- [) (NP (CD 10))) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (NP (NNP Holler)) (ADVP-ETC (FW et) (FW al.))) (VP (VBD reported) (SBAR (IN that) (S (NP-SBJ (NP (NP (DT the) (CD three) (JJ major) (NNS mutations)) (VP (VBN associated) (NP (-NONE- *)) (PP (IN with) (NP (NN CD))))) (-LRB- -LRB-) (NP (NN R702W) (, ,) (NN G908R) (CC and) (NN 1007fs))) (-RRB- -RRB-) (VP (VBP are) (ADVP (RB also)) (ADJP-PRD (JJ associated) (PP (IN with) (NP (NP (JJ severe) (JJ acute) (NN GVHD)) (CC and) (NP (ADJP (NP (NP (NML (NN bone) (NN marrow)) (NN transplantation)) (-LRB- -LRB-) (NP (NN BMT))) (-RRB- -RRB-) (VBN related)) (NN mortality))))) (PRN (-LRB- [) (NP (CD 3)) (-RRB- ])))))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Mutations)) (PP-LOC (IN in) (NP (CC both) (NN donor) (CC and) (NN recipient)))) (VP (VBD were) (VP (VBN found) (S (NP-SBJ-1 (-NONE- *)) (ADJP-PRD (JJ deleterious))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG suggesting) (NP (NP (DT a) (NN role)) (PP (IN of) (NP (ADJP (JJ epithelial) (CC and) (VBG circulating)) (NNS cells))) (PP (IN in) (NP (NN disease) (NNS mechanisms)))))))) (. .)) )
( (S (PP (IN Despite) (NP (NP (DT some) (NNS differences)) (PP (IN in) (NP (PRP$ their) (NNS conclusions))))) (, ,) (NP-SBJ (JJ other) (NNS groups)) (ADVP-TMP (RB recently)) (VP (VBD confirmed) (NP (NP (DT the) (NN association)) (PP (IN between) (NP (NML (NN NOD2) (CC and) (NN BMT)) (NNS complications)))) (PRN (-LRB- [) (NP (CD 4)) (-RRB- ])) (, ,) (PRN (-LRB- [) (NP (CD 11)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (NN CD)) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ chronic) (VBG relapsing) (NML (NML (JJ inflammatory) (NN bowel) (NN disease)) (-LRB- -LRB-) (NML (NN IBD)))) (-RRB- -RRB-) (PP (IN with) (NP (NP (JJ mucosal) (NNS ulcerations)) (PP (IN of) (NP (DT the) (JJ digestive) (NN tract))))))) (. .)) )
( (S (S (NP-SBJ-1 (NN CD) (NNS lesions)) (VP (VBP are) (VP (VBN characterised) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (DT a) (NML (NML (NML (NN T) (NN helper)) (-LRB- -LRB-) (NML (NN Th))) (-RRB- -RRB-) (CD 1)) (JJ immune) (NN response)))))) (CC and) (S (NP-SBJ (JJ several) (NNS authors)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP-SBJ-2 (PRP they)) (VP (VBP are) (VP (VBN related) (NP-2 (-NONE- *)) (PP (IN with) (NP (NP (NP (ADJP (NN gut) (VBN associated)) (JJ lymphoid) (NN tissue)) (-LRB- -LRB-) (NP (NN GALT))) (-RRB- -RRB-) (, ,) (VP (VBN known) (NP (-NONE- *)) (PP (IN as) (NP (NP (JJ lymphoid) (NNS follicles)) (-LRB- -LRB-) (NP (NNS LFs)))))))))))))) (-RRB- -RRB-) (. .)) )
( (S (NP-SBJ-1 (NNS LFs)) (VP (VBP are) (ADVP (RB mainly)) (VP (VBN encountered) (NP-1 (-NONE- *)) (PP-LOC (PP (IN in) (NP (NP (DT the) (NN colon)) (SBAR (WHADVP-2 (WRB where)) (S (NP-SBJ-6 (PRP they)) (VP (VBP are) (VP (VBN isolated) (NP-6 (-NONE- *)) (ADVP-LOC-2 (-NONE- *T*)))))))) (CC and) (PP (IN in) (NP (NP (JJ small) (NN bowel)) (SBAR (WHADVP-5 (WRB where)) (S (NP-SBJ-4 (PRP they)) (VP (VBP are) (VP (VBN grouped) (NP-4 (-NONE- *)) (ADVP-LOC-5 (-NONE- *T*)) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG forming) (NP (NP (NP (NP (NNP Peyer) (POS 's)) (NNS patches)) (-LRB- -LRB-) (NP (NNS PP))) (-RRB- -RRB-) (SBAR (WHNP-3 (WDT which)) (S (NP-SBJ-3 (-NONE- *T*)) (VP (VBP are) (VP (VBN known) (S (NP-SBJ-3 (-NONE- *)) (VP (TO to) (VP (VB be) (NP-PRD (NP (JJ pivotal) (NNS sites)) (PP (PP (IN for) (NP (DT the) (NN host) (JJ immune) (NN response))) (CC and) (PP (IN for) (NP (NP (DT the) (NN entry)) (PP (IN of) (NP (NN enteropathogen) (NNS bacteria)))))))))))))))))))))))))) (. .)) )
( (S (NP-SBJ-1 (NN CD) (NNS lesions)) (VP (VBP are) (ADVP-TMP (RBS most) (RB often)) (VP (VBN localized) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NP (NN colon)) (CC and) (NP (JJ distal) (NN ileum))) (, ,) (SBAR (WHADVP-2 (WRB where)) (S (NP-SBJ (DT the) (NNS LFs)) (VP (VBP are) (ADJP-PRD (DT the) (RBS most) (JJ abundant)) (ADVP-LOC-2 (-NONE- *T*))))))) (PRN (-LRB- [) (NP (CD 12)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ (NP (NNP Fujimura)) (ADVP-ETC (FW et) (FW al.))) (VP (VBD found) (SBAR (IN that) (S (NP-SBJ-1 (NP (NN aphtoïd) (NNS ulcerations)) (-LRB- -LRB-) (SBAR (WHNP-2 (WDT which)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBP are) (ADVP-TMP (RB often)) (VP (VBN considered) (NP-2 (-NONE- *)) (PP (IN as) (NP (DT the) (JJS earliest) (NN CD) (NNS lesions)))))))) (-RRB- -RRB-) (VP (VBP are) (VP (VBN centred) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NNS LFs))) (PRN (-LRB- [) (NP (CD 13)) (-RRB- ]))))))) (. .)) )
( (S (PP (IN In) (NP (NP (NN addition)) (PP (IN to) (NP (DT this) (JJ spatial) (NN relationship))))) (, ,) (NP-SBJ-1 (NP (DT a) (JJ temporal) (NN link)) (PP (IN between) (NP (NML (NN CD) (CC and) (NN PP)) (NN development)))) (VP (VBZ has) (ADVP (RB also)) (VP (VBN been) (VP (VBN suggested) (NP-1 (-NONE- *)) (PRN (-LRB- [) (NP (CD 14)) (-RRB- ]))))) (. .)) )
( (S (NP-SBJ (NNS PPs)) (VP (VP (VBP develop) (PP-TMP (PP (IN from) (NP (NN birth))) (PP (IN to) (NP (NP (QP (CD 10) (SYM –) (CD 15)) (NNS years)) (PP (IN of) (NP (NN life))))))) (CC and) (VP (ADVP-TMP (RB then)) (VBP undergo) (NP (NN involution)))) (. .)) )
( (S (NP-SBJ (NP (DT The) (ADJP (NN age) (HYPH -) (JJ dependent)) (NN incidence) (NN curve)) (PP (IN of) (NP (NN CD)))) (VP (VBZ is) (ADJP-PRD (RB roughly) (JJ parallel) (PP (IN to) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NN PP)))))) (PP (IN with) (NP (NP (DT a) (NN delay)) (PP (IN of) (NP (QP (IN about) (CD 10)) (NNS years)))))) (. .)) )
( (S (ADVP (RB Finally)) (, ,) (NP-SBJ (JJ ileal) (NNS lesions)) (VP (VBP are) (ADJP-PRD (JJ uncommon)) (PP-LOC (IN in) (NP (NP (NP (JJ young) (NNS children)) (CC and) (NP (NNS seniors))) (SBAR (WHADVP-1 (WRB where)) (S (NP-SBJ (NNS PP)) (VP (VBP are) (ADJP-PRD (JJ rare)) (ADVP-LOC-1 (-NONE- *T*))))))) (PRN (-LRB- [) (NP (CD 15)) (-RRB- ])) (, ,) (PRN (-LRB- [) (NP (CD 16)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NN role)) (PP (IN of) (NP (NN GALT))) (PP (IN in) (NP (NN GVHD)))) (VP (VBZ has) (VP (VBN been) (VP (VBN suspected) (NP-1 (-NONE- *)) (PP (IN on) (NP (CC both) (NP (JJ experimental) (NNS models)) (CC and) (NP (JJ clinical) (NNS observations))))))) (. .)) )
( (S (NP-SBJ (NN Animal) (NNS studies)) (VP (VBD showed) (SBAR (SBAR (IN that) (S (NP-SBJ-1 (NP (NN death)) (PP-TMP (IN after) (NP (NN BMT)))) (VP (VBD was) (VP (VBN prevented) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NN gut) (NN decontamination))))))) (CC and) (SBAR (IN that) (S (NP-SBJ (NP (NN prevention)) (PP (IN of) (NP (JJ mucosal) (NN damage)))) (ADVP (RB also)) (VP (VBZ prevents) (NP (JJ lethal) (NN GVHD)) (PRN (-LRB- [) (NP (CD 17)) (-RRB- ]))))))) (. .)) )
( (S (PP (IN In) (NP (JJ clinical) (NN practice))) (, ,) (NP-SBJ (NN gut) (NN decontamination)) (VP (VBZ reduces) (NP (NP (DT the) (NML (NN frequency) (CC and) (NN severity))) (PP (IN of) (NP (NN GVHD))))) (. .)) )
( (S (ADVP (RB Finally)) (, ,) (NP-SBJ (NP (NNP Murai)) (ADVP-ETC (FW et) (FW al.))) (ADVP-TMP (RB recently)) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ (ADJP (NN PP) (JJ deficient)) (NNS mice)) (VP (VBP are) (ADJP-PRD (JJ resistant) (PP (IN to) (NP (NN GVHD)))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG arguing) (PP (IN for) (NP (NP (DT a) (JJ crucial) (NN role)) (PP (IN of) (NP (NNS PPs))) (PP (IN in) (NP (NN GVHD))))) (, ,) (PP-LOC (ADVP (RB at) (RBS least)) (IN in) (NP (NP (NNS models)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP do) (RB not) (VP (VB use) (NP (NP (NN conditioning)) (PP (IN of) (NP (DT the) (NN host)))) (PP-TMP (JJ prior) (PP (IN to) (NP (NP (JJ adoptive) (NN transfer)) (PP (IN of) (NP (DT the) (JJ allogeneic) (NN donor) (NNS cells)))))) (PRN (-LRB- [) (NP (CD 18)) (-RRB- ])) (, ,) (PRN (-LRB- [) (NP (CD 19)) (-RRB- ])))))))))))))) (. .)) )
( (S (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG Considering) (NP (PDT all) (DT these) (NNS elements)))) (, ,) (NP-SBJ (PRP we)) (VP (VBD hypothesized) (SBAR (IN that) (S (NP-SBJ (NN Nod2)) (VP (MD may) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (NP (NP (DT the) (NML (NN structure) (CC and) (NN function))) (PP (IN of) (NP (DT the) (NN GALT)))))))))) (. .)) )
( (S (ADVP (RB Consequently)) (, ,) (NP-SBJ (PRP we)) (VP (VBD used) (NP (NP (DT a) (JJ new) (NN mouse) (NN model)) (ADJP (JJ deficient) (PP (IN for) (NP (NN Card15) (HYPH /) (NN Nod2))))) (S-PRP (S (LST (LS i) (-RRB- -RRB-)) (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB evaluate) (NP (NP (DT the) (NN involvement)) (PP (IN of) (NP (NN Nod2))) (PP (IN on) (NP (NP (DT the) (NN number)) (CC and) (NP (NP (NNS PPs)) (NN size)))))))) (: ;) (S (LST (LS ii) (-RRB- -RRB-)) (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB assess) (SBAR (IN whether) (S (NP-SBJ (NN Nod2)) (VP (VBN modified) (NP (NP (NP (JJ cellular) (NN composition)) (CC and) (NP (NN cytokine) (NN expression))) (PP (IN of) (NP (NNS PPs)))))))))) (: ;) (CC and) (S (LST (LS iii) (-RRB- -RRB-)) (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP-SBJ (NN Nod2)) (VP (MD may) (VP (VB alter) (NP (NP (NP (JJ paracellular) (NN permeability)) (CC and) (NP (JJ bacterial) (NN translocation))) (PP (IN of) (NP (NNS PPs))) (PP-LOC (IN in) (NP (JJ adult) (NNS mice))))))))))))) (. .)) )
( (S (ADVP (RB Finally)) (, ,) (NP-SBJ (PRP we)) (ADVP (RB also)) (VP (VBD examined) (SBAR (IN if) (S (NP-SBJ (NML (NN Card15) (HYPH /) (NN Nod2)) (NN deficiency)) (VP (VBZ affects) (NP (NP (NP (DT the) (JJ colonic) (NN response)) (PP (IN to) (NP (NP (CD 2) (, ,) (CD 4) (, ,) (CD 6) (HYPH -) (NN trinitrobenzene) (JJ sulphonic) (NN acid)) (-LRB- -LRB-) (NP (NN TNBS))))) (-RRB- -RRB-) (, ,) (NP (NP (DT a) (JJ classic) (JJ experimental) (NN model)) (PP (IN of) (NP (NN colitis))) (PP-LOC (IN in) (NP (NN mouse))))))))) (. .)) )
( (HEADING (NP (NNS Results))) )
( (S (NP-SBJ (NP (NNP Body) (NN weight)) (, ,) (NP (JJ intestinal) (NN length)) (CC and) (NP (JJ intestinal) (NN weight))) (VP (VBD were) (ADJP-PRD (JJ similar)) (PP-LOC (IN in) (NP (NML (NN KO) (CC and) (NN WT)) (NNS mice))) (PRN (-LRB- -LRB-) (NP (NP (JJ supplementary) (NN information)) (-LRB- -LRB-) (NP (NN SI))) (-RRB- -RRB-) (NP (NN Table) (NN S1)) (-RRB- -RRB-))) (. .)) )
( (S (ADVP (RB Macroscopically)) (, ,) (NP-SBJ (DT no) (NN inflammation)) (VP (VBD was) (ADJP-PRD (JJ visible)) (PP-LOC (IN in) (NP (NN KO) (NNS mice))) (PP-MNR (VBG according) (PP (IN to) (NP (NML (NNP Wallace) (CC and) (NNP Ameho)) (NNS criteria)))) (PRN (-LRB- -LRB-) (S (NP-SBJ-1 (NNS data)) (RB not) (VP (VBN shown) (NP-1 (-NONE- *)))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (NN KO) (NNS mice)) (VP (VBD exhibited) (NP (NP (DT an) (VBN increased) (NN number)) (PP (IN of) (NP (NN PP))) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (NN WT) (NNS mice)))))) (PP-TMP (IN at) (NP (NP (NNS weeks) (NML (CD 4) (, ,) (CD 12) (CC and) (CD 52))) (PP-TMP (IN after) (NP (NN birth))))) (PRN (-LRB- -LRB-) (NP (NN Fig) (CD 1) (NN A)) (-RRB- -RRB-))) (. .)) )
( (S (PP-TMP (IN At) (NP (NNS weeks) (NML (CD 12) (CC and) (CD 52)))) (, ,) (NP-SBJ (NP (DT the) (NN number)) (PP (IN of) (NP (NP (VBN isolated) (NNS LFs)) (PP (IN per) (NP (JJ small) (NN intestine)))))) (VP (VBD was) (ADVP (RB also)) (ADJP-PRD (ADJP (JJR higher)) (PP-1 (-NONE- *ICH*))) (PP-LOC (IN in) (NP (NN KO) (NNS mice))) (PP-1 (IN than) (PP-LOC (IN in) (NP (NN WT) (NNS mice)))) (PRN (-LRB- -LRB-) (NP (NN Fig) (CD 1) (NN B)) (-RRB- -RRB-))) (. .)) )
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (NP (DT the) (NN number)) (PP (IN of) (NP (NNS PPs))) (PP-TMP (IN at) (NP (NN birth)))) (VP (VBD was) (ADJP-PRD (JJ similar) (PP (IN between) (NP (NML (NN KO) (CC and) (NN WT)) (NNS mice)))) (PRN (-LRB- -LRB-) (NP (NP (QP (CD 6.2) (SYM ±) (CD 0.5))) (CC vs.) (NP (QP (CD 6.0) (SYM ±) (CD 0.4)))) (: ;) (S-FRM (NP-SBJ (NN P)) (VP (SYM >) (NP (CD 0.05)))) (-RRB- -RRB-)) (PRN (-LRB- -LRB-) (NP (NN Fig) (CD 1) (NN A)) (-RRB- -RRB-))) (. .)) )
( (S (ADVP (RB Macroscopically)) (, ,) (NP-SBJ-1 (NP (DT the) (NN size)) (PP (IN of) (NP (NN PP) (NNS formations)))) (VP (VBD appeared) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (ADJP-PRD (JJR larger)) (PP-LOC (IN in) (NP (JJ adult) (NN KO) (NNS mice))) (PRN (-LRB- -LRB-) (S (NP-SBJ-2 (NNS data)) (RB not) (VP (VBN shown) (NP-2 (-NONE- *)))) (-RRB- -RRB-)))))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB quantify) (NP (DT this) (NN difference))))) (, ,) (S (S (NP-SBJ-2 (NP (DT the) (CD three) (JJS biggest) (NNS PPs)) (PP (IN of) (NP (DT each) (NN mouse)))) (VP (VBD were) (VP (VBN pooled) (NP-2 (-NONE- *))))) (CC and) (S (NP-SBJ-1 (PRP$ their) (NNS cells)) (VP (VBD were) (VP (VBN counted) (NP-1 (-NONE- *)))))) (. .)) )
( (S (PP-TMP (IN At) (NP (NNS weeks) (NML (CD 4) (, ,) (CD 12) (CC and) (CD 52)))) (, ,) (NP-SBJ (NN KO) (NNS mice)) (VP (VBD exhibited) (NP (NP (DT a) (JJR higher) (NN cell) (NN number)) (PP (IN per) (NP (NN PP)))) (PRN (-LRB- -LRB-) (NP (NN fig) (CD 1) (NN C)) (-RRB- -RRB-))) (. .)) )
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (NN cell) (NNS counts)) (VP (VBD were) (ADJP-PRD (JJ comparable)) (PP-LOC (IN in) (NP (NP (NNS spleens)) (PP (IN of) (NP (NML (NN KO) (CC and) (NN WT)) (NNS mice))))) (PRN (-LRB- -LRB-) (NP (NN Fig) (CD 1) (NN D)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (NP (JJ Microscopic) (NNS analyses)) (PP (IN of) (NP (NN PP) (NNS formations))) (PP (IN from) (NP (NN KO) (NNS mice)))) (VP (VBD revealed) (NP (DT no) (JJ gross) (NNS abnormalities)) (PRN (-LRB- -LRB-) (NP (NN Fig) (CD 1) (NN E)) (-RRB- -RRB-))) (. .)) )
( (S (ADVP (RB Finally)) (, ,) (SBAR-PRP (IN as) (S (NP-SBJ (NN NOD2)) (VP (VBZ modulates) (NP (NP (DT the) (NML (NN NF) (HYPH -) (NN κappaB)) (NN pathway)) (CC and) (NP (ADVP (RB putatively)) (DT the) (NN apoptosis)))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD investigated) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (JJ apoptotic) (NNS cells))) (PP-LOC (IN inside) (NP (NNS PPs))))) (. .)) )
( (S (NP-SBJ (NN Immunohistochemistry) (NNS experiments)) (VP (VBD did) (RB not) (VP (VB show) (NP (NP (NNS differences)) (PP (IN between) (NP (NML (NN KO) (CC and) (NN WT)) (NNS mice))) (PP (IN for) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (ADJP (NP (NN caspase) (CD 3)) (JJ positive)) (NNS cells))))) (PRN (-LRB- -LRB-) (NP (NP (QP (CD 1.01) (SYM ±) (CD 0.11))) (CC vs.) (NP (QP (CD 1.32) (SYM ±) (CD 0.10)))) (: ;) (S-FRM (NP-SBJ (NN P)) (VP (SYM >) (NP (CD 0.05)))) (-RRB- -RRB-)) (PRN (-LRB- -LRB-) (NP (NN Fig) (CD 1) (NN E)) (-RRB- -RRB-))))) (. .)) )
( (S (PP-PRP (IN In) (NP (NN order) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (ADVP (RBR better)) (VP (VB characterise) (NP (NP (DT the) (NN phenotype)) (PP (IN of) (NP (NP (DT the) (NNS cells)) (RRC (ADJP-PRD (JJ present)) (PP-LOC (IN in) (NP (NNS PPs)))))))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD performed) (NP (NML (NN flow) (NN cytometry)) (NNS experiments)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT the) (NML (NN B220) (, ,) (NN CD3) (CC and) (NN CD11c)) (NNS antibodies))))) (. .)) )
( (S (PP-TMP (IN At) (NP (NN week) (CD 12))) (, ,) (NP-SBJ-1 (NP (DT no) (NNS differences)) (VP-2 (-NONE- *ICH*))) (VP (VBD were) (VP (VBN seen) (NP-1 (-NONE- *)) (PP-2 (VBG regarding) (NP (NP (DT the) (JJ relative) (NNS proportions)) (PP (IN of) (NP (NP (NML (NN B220) (SYM +)) (NN B) (HYPH -) (NNS cells)) (, ,) (NP (NML (NN CD3) (SYM +)) (NN T) (HYPH -) (NNS cells)) (CC and) (NP (NML (NN CD11c) (SYM +)) (JJ dendritic) (NNS cells)))) (PP (IN between) (NP (NML (NN KO) (CC and) (NN WT)) (NNS mice))) (PP (CC either) (IN for) (NP (NNS PPs) (CC or) (NNS spleens)))) (PRN (-LRB- -LRB-) (NP (NP (NN Fig) (CD 2) (NN A)) (PP (SYM –) (NP (NN B)))) (-RRB- -RRB-))))) (. .)) )
( (S (SBAR-PRP (IN Because) (S (NP-SBJ (NP (DT some) (NNS cells)) (RRC (ADJP-PRD (JJ present)) (PP (IN in) (NP (DT a) (VBN limited) (NN number))))) (VP (MD may) (VP (VB be) (ADJP-PRD (RB functionally) (JJ important)))))) (, ,) (NP-SBJ (PRP we)) (ADVP (RB also)) (VP (VBD investigated) (NP (NP (NP (DT the) (JJ relative) (NN proportion)) (PP (IN of) (NP (NP (NML (NML (NN Ly) (HYPH -) (NN 6G)) (SYM +)) (NML (NML (JJ polymorphonuclear) (NNS neutrophils)) (-LRB- -LRB-) (NML (NN PMN)))) (-RRB- -RRB-) (RRC (ADJP-PRD (JJ present)) (PP-LOC (IN in) (NP (DT the) (NNS PPs))) (PRN (-LRB- -LRB-) (NP (NN Fig) (CD 2) (NN C)) (-RRB- -RRB-)))))) (CC and) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NN M) (NNS cells)) (VP (VBN located) (NP (-NONE- *)) (PP-LOC (IN inside) (NP (NP (DT the) (ADJP (NN follicle) (VBN associated)) (NN epithelium)) (-LRB- -LRB-) (NP (NN FAE)))))))) (-RRB- -RRB-) (PRN (-LRB- -LRB-) (NP (NN Fig) (CD 2) (NN D)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (NP (DT No) (NN difference)) (PP (IN of) (NP (NN PMN) (JJ relative) (NN proportion)))) (VP (VBD was) (VP (VBN observed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NNS PPs)) (PP (IN of) (NP (NML (NN KO) (CC and) (NN WT)) (NNS mice))))) (PRN (-LRB- -LRB-) (NP (NN Fig) (CD 2) (NN C)) (-RRB- -RRB-)))) (. .)) )
( (S (PP (IN At) (NP (DT the) (JJ opposite))) (, ,) (NP-SBJ-1 (NML (NN M) (NN cell)) (NN number)) (VP (VBD was) (VP (VBN increased) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT the) (NN FAE)) (PP (IN of) (NP (NN KO) (NNS mice))))) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (NN WT) (NNS mice))))) (PRN (-LRB- -LRB-) (NP (NN Fig) (CD 2) (NN D)) (-RRB- -RRB-)))) (. .)) )
( (S (SBAR-PRP (IN As) (S (NP-SBJ-1 (NN T) (HYPH -) (NNS cells)) (VP (VBP are) (VP (VBN known) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB play) (NP (NP (DT a) (JJ pivotal) (NN role)) (PP (IN in) (NP (NN CD))))))))))) (, ,) (NP-SBJ (PRP we)) (ADVP (RB further)) (VP (VBD analyzed) (NP (DT the) (NML (NN CD3) (SYM +)) (NN T) (NNS cells))) (. .)) )
( (S (PP-TMP (IN At) (NP (NN week) (CD 12))) (, ,) (NP-SBJ (NN KO) (NNS mice)) (VP (VBD exhibited) (NP (NP (DT an) (NN increase)) (PP (IN of) (NP (NML (NML (NN CD4) (SYM +)) (NML (NN T) (HYPH -) (NN cell))) (JJ relative) (NN proportion))) (PP (IN within) (NP (PRP$ their) (NNS PPs)))) (, ,) (SBAR-ADV (IN whereas) (S (NP-SBJ-1 (NP (DT the) (NN proportion)) (PP (IN of) (NP (NML (NN CD8) (SYM +)) (NN T) (HYPH -) (NNS cells)))) (VP (VBD remained) (S (NP-SBJ-1 (-NONE- *)) (ADJP-PRD (JJ constant)))))) (PRN (-LRB- -LRB-) (NP (NN Fig) (CD 3) (NN A)) (-RRB- -RRB-))) (. .)) )
( (S (PP (IN As) (NP (DT a) (NN mirror) (NN image))) (, ,) (NP-SBJ (NP (NNS PPs)) (PP (IN from) (NP (NN KO) (NNS mice)))) (VP (VBD exhibited) (NP (ADJP (RB significantly) (JJR fewer)) (NML (NN CD3) (SYM +)) (NML (NN CD4) (SYM −)) (NML (NN CD8) (SYM −)) (NN T) (SYM -) (NNS cells) (PRN (-LRB- -LRB-) (NP (NN Fig) (CD 3) (NN A)) (-RRB- -RRB-)))) (. .)) )
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ-1 (DT no) (JJ comparable) (NNS differences)) (VP (VBD were) (VP (VBN seen) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NNS spleens))) (PRN (-LRB- -LRB-) (NP (NN Fig) (CD 3) (NN B)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (JJ Similar) (NNS data)) (VP (VBD were) (VP (VBN obtained) (NP-1 (-NONE- *)) (PP-TMP (IN at) (NP (NN week) (CD 4))) (PRN (-LRB- -LRB-) (NP (NP (NN SI) (NN Fig) (NN S1) (NN A)) (PP (SYM –) (NP (NN B)))) (-RRB- -RRB-)))) (. .)) )
( (S (ADVP (RB Finally)) (, ,) (NP-SBJ (PRP we)) (VP (VBD investigated) (NP (NP (DT the) (NN phenotype)) (PP (IN of) (NP (NP (NML (NN CD4) (SYM +)) (NN T) (HYPH -) (NNS cells)) (RRC (ADJP-PRD (JJ present)) (PP-LOC (IN in) (NP (DT the) (NML (NNS PPs) (CC and) (NNS spleens)))))))) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG examining) (NP (NP (DT the) (JJ relative) (NNS proportions)) (PP (IN of) (NP (NP (JJ naive) (NML (NN CD25) (SYM −)) (NML (NN CD45Rb) (SYM +)) (NML-1 (-NONE- *RNR*))) (, ,) (NP (JJ regulatory) (NML (NN CD25) (SYM +)) (NML (NN CD45Rb) (SYM −)) (NML-1 (-NONE- *RNR*))) (CC and) (NP (NN memory) (NML (NN CD25) (SYM −)) (NML (NN CD45Rb) (SYM −)) (NML (NN CD4) (SYM +)) (NML-1 (-NONE- *RNR*))) (NML-1 (NN T) (HYPH -) (NNS cells))))))))) (. .)) )
( (S (NP-SBJ (NML (NN KO) (CC and) (NN WT)) (NNS mice)) (VP (VBD had) (NP (NP (DT a) (JJ similar) (JJ relative) (NN proportion)) (PP (IN of) (NP (UCP (JJ naive) (, ,) (JJ regulatory) (CC and) (NN memory)) (NML (NN CD4) (SYM +)) (NN T) (HYPH -) (NNS cells)))) (PP-LOC (IN in) (NP (NP (NNS PPs) (PRN (-LRB- -LRB-) (NP (NN SI) (NN Fig) (NN S2) (NN A)) (-RRB- -RRB-))) (CC and) (NP (NN spleen) (PRN (-LRB- -LRB-) (NP (NN SI) (NN Fig) (NN S2) (NN B)) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ-1 (NML (NN Flow) (NN cytometry)) (NNS analyses)) (ADVP (RB also)) (VP (VBD failed) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB reveal) (NP (NP (DT a) (NN difference)) (PP (IN between) (NP (NML (NN KO) (CC and) (NN WT)) (NNS mice)))) (SBAR-TMP (WHADVP-2 (WRB when)) (S (NP-SBJ (-NONE- *PRO*)) (VP (VBG investigating) (NP (NP (NP (DT the) (ADJP (NP (NN annexin) (CD V)) (JJ positive)) (NML (NN CD3) (SYM +)) (NML-3 (-NONE- *))) (CC and) (NP (NML (NN CD3) (SYM +)) (NML (NN CD4) (SYM +)) (NML (-NONE- *))) (NML-3 (NN T) (HYPH -) (NNS cells))) (VP (VBN extracted) (NP (-NONE- *)) (PP (IN from) (NP (NNS PPs))) (PRN (-LRB- -LRB-) (NP (NN SI) (NN Fig) (NN S2) (NN C)) (-RRB- -RRB-)))) (ADVP-TMP-2 (-NONE- *T*))))) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ (NP (NP (DT the) (NN excess)) (PP (IN of) (NP (NML (NN CD4) (SYM +)) (NN T) (HYPH -) (NNS cells)))) (VP (VBN observed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NN KO) (NNS mice))))) (VP (VBZ does) (RB not) (VP (VB result) (PP (IN from) (NP (NP (DT a) (NN defect)) (PP (IN of) (NP (NN apoptosis))))))))))))))) (. .)) )
( (S (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG Considering) (NP (NP (DT the) (NNS differences)) (PP (IN of) (NP (NN PP) (NML (NML (NN cell) (NN number)) (CC and) (NML (JJ cellular) (NN composition)))))))) (, ,) (NP-SBJ (PRP we)) (ADVP (RB further)) (VP (VBD evaluated) (SBAR (IN whether) (S (NP-SBJ (NP (NNS PPs)) (PP (IN from) (NP (NML (NN KO) (CC and) (NN WT)) (NNS mice)))) (VP (MD might) (VP (VB exhibit) (NP (NP (NNS differences)) (VP (VBG regarding) (NP (PRP$ their) (NN cytokine) (NN profile))))))))) (. .)) )
( (S (ADVP (RB Thus)) (, ,) (NP-SBJ-1 (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (NN IL) (HYPH -) (NN 1β)) (, ,) (NP (NN IFNγ)) (, ,) (NP (NN TNFα)) (, ,) (NP (NN IL) (HYPH -) (CD 12)) (, ,) (CC and) (NP (NN IL) (HYPH -) (CD 4)))) (PP-LOC (IN in) (NP (NP (NNS PPs)) (, ,) (NP (ADJP (NN PP) (HYPH -) (JJ free)) (NN ileum)) (CC and) (NP (NN spleen))))) (VP (VBD were) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NNP ELISA))) (, ,) (PP-TMP (IN at) (NP (NNS weeks) (NML (CD 4) (CC and) (CD 12)))))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Levels)) (PP (IN of) (NP (NP (NN IFNγ)) (, ,) (NP (NN TNFα)) (, ,) (NP (NN IL) (HYPH -) (CD 12)) (, ,) (CC and) (NP (NN IL) (HYPH -) (CD 4))))) (VP (VBD were) (ADVP (RB significantly)) (VP (VBN increased) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NNS PPs)) (PP (IN of) (NP (NN KO) (NNS mice)))))) (PRN (-LRB- -LRB-) (NP (NN Fig) (CD 4)) (-RRB- -RRB-))) (. .)) )
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ-1 (ADJP (RBR less) (JJ marked)) (NNS differences)) (VP (VBD were) (VP (VBN seen) (NP-1 (-NONE- *)) (PP (IN between) (NP (NML (NN KO) (CC and) (NN WT)) (NNS mice))) (PP-LOC (IN in) (NP (NP (ADJP (NN PP) (HYPH -) (JJ free)) (NN ileum)) (SBAR (WHADVP-2 (WRB where)) (S (NP-SBJ (NN TNFα) (CC and) (NN IFNγ)) (VP (VBD were) (NP-PRD (NP (DT the) (JJ only) (NNS cytokines)) (VP (ADVP (RB differentially)) (VBN expressed) (NP (-NONE- *)) (PP (PP-TMP (IN at) (NP (NN week) (CD 4))) (CONJP (CC but) (RB not)) (PP-LOC (IN in) (NP (JJ adult) (NNS mice)))))) (ADVP-LOC-2 (-NONE- *T*))))))) (PRN (-LRB- -LRB-) (NP (NN Fig) (CD 4)) (-RRB- -RRB-)))) (. .)) )
( (S (ADVP (RB Finally)) (, ,) (NP-SBJ-1 (DT no) (NNS differences)) (VP (VBD were) (VP (VBN observed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NNS spleens)) (PP (IN from) (NP (NML (NN KO) (CC and) (NN WT)) (NNS mice))))) (PRN (-LRB- -LRB-) (NP (NN Fig) (CD 4)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (NP (NN Cell) (NN composition)) (CC and) (NP (NN cytokine) (NN production))) (VP (MD may) (VP (VB affect) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (NNS PPs)))))) (. .)) )
( (S (NP-SBJ (PRP We)) (ADVP (RB thus)) (VP (VBD used) (NP (NNP Ussing) (NNS chambers)) (PP-PRP (IN for) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG determining) (NP (DT the) (JJ paracellular) (NN permeability)) (PP-MNR (IN through) (NP (NP (NNS PP)) (CC and) (NP (ADJP (NNS PP) (HYPH -) (JJ free)) (NN ileum)))))))) (. .)) )
( (S (NP-SBJ (NP (NP (NNS PPs)) (CC and) (NP (ADJP (NNS PP) (HYPH -) (JJ free)) (NN ileum))) (PP (IN of) (NP (NN KO) (NNS mice)))) (VP (VBD exhibited) (NP (NP (DT a) (JJ significant) (NN increase)) (PP (IN in) (NP (JJ paracellular) (NN permeability))) (PRN (-LRB- -LRB-) (NP (NN Fig) (CD 5) (NN A)) (-RRB- -RRB-))) (SBAR-ADV (IN while) (S (NP-SBJ (DT the) (JJ electrical) (NNS resistances)) (VP (VBD were) (ADJP-PRD (JJ comparable)) (PRN (-LRB- -LRB-) (S (NP-SBJ-1 (NNS data)) (RB not) (VP (VBN shown) (NP-1 (-NONE- *)))) (-RRB- -RRB-)))))) (. .)) )
( (S (PP (IN In) (NP (NP (NN parallel)) (PP (IN to) (NP (DT this) (NN change))))) (, ,) (NP-SBJ-1 (NP (NML (NN mRNA) (NN expression)) (NNS levels)) (PP (IN of) (NP (NN TJ) (NN proteins)))) (VP (VBD were) (VP (VBN affected) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NNS PP)) (PP (IN of) (NP (NN KO) (NNS mice))))))) (. .)) )
( (S (ADVP (RB Indeed)) (, ,) (NP-SBJ-1 (NP (NN expression)) (PP (IN of) (NP (NP (NNS mRNAs)) (VP (VBG encoding) (NP (NP (NN ZO) (HYPH -) (CD 2)) (CC and) (NP (NN ZO) (HYPH -) (CD 1))))))) (VP (VBD were) (VP (VBN decreased) (NP-1 (-NONE- *)) (PP-EXT (IN by) (NP (NP (CD 45) (NN %)) (CC and) (NP (CD 36) (NN %)))) (PRN (-LRB- -LRB-) (S (S-FRM (NP-SBJ (NN P)) (VP (SYM <) (NP (CD 0.01)))) (CC and) (S-FRM (NP-SBJ (NN P)) (VP (SYM <) (NP (CD 0.06)) (ADVP (RB respectively))))) (-RRB- -RRB-)) (PRN (-LRB- -LRB-) (NP (NN Fig) (CD 5) (NN B)) (-RRB- -RRB-)))) (. .)) )
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (NN Occludin) (NN expression)) (VP (VBD was) (ADJP-PRD (JJ unchanged)) (PRN (-LRB- -LRB-) (NP (NN Fig) (CD 5) (NN B)) (-RRB- -RRB-))) (. .)) )
( (S (SBAR-PRP (IN Because) (S (NP-SBJ-1 (NN Nod2)) (VP (VBZ is) (VP (VBN involved) (NP-1 (-NONE- *)) (PP (IN in) (NP (JJ innate) (NN immunity))))))) (NP-SBJ (PRP we)) (VP (VBD hypothesised) (SBAR (IN that) (S (NP-SBJ (NML (NN Card15) (HYPH /) (NN Nod2)) (NN deficiency)) (VP (MD may) (VP (VB affect) (NP (DT the) (NN gut) (NNS microflora))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (ADVP (RB thus)) (VP (VBD counted) (NP (NP (DT the) (NNS numbers)) (PP (IN of) (NP (NP (NNS bacteria)) (VP (VBN classified) (NP (-NONE- *)) (PP (IN as) (NP (NNP Enterobacteriaceae) (, ,) (NNP Pseudomonas) (, ,) (NNP Staphylococcus) (, ,) (NNP Streptococcus) (, ,) (NNP Enterococcus) (CC or) (NNP Lactobacillus)))))) (PP-LOC (IN in) (NP (NP (DT the) (NN ileum)) (PP (IN of) (NP (NML (NN KO) (CC and) (NN WT)) (NNS mice))))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ (PRP we)) (VP (VBD did) (RB not) (VP (VB observed) (NP (NP (NNS differences)) (PP (IN between) (NP (NNS groups)))) (PRN (-LRB- -LRB-) (NP (NN SI) (NN Table) (NN S2)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (NML (NNP Ussing) (NN chamber)) (NNS experiments)) (VP (VBD were) (ADVP (RB also)) (VP (VBN performed) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (JJ bacterial) (NN passage)) (PP (IN through) (NP (NNS PP))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN passage)) (PP (IN of) (NP (NP (DT a) (ADJP (RB chemically) (VBN killed)) (FW Escherichia) (FW coli)) (-LRB- -LRB-) (NP (NN K) (HYPH -) (CD 12))))) (-RRB- -RRB-) (VP (VBD was) (ADJP-PRD (JJR higher)) (PP-LOC (IN in) (NP (NP (NN PP)) (PP (IN of) (NP (NN KO) (NNS mice))))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN P)) (VP (SYM <) (NP (CD 0.01)))) (-RRB- -RRB-)) (PRN (-LRB- -LRB-) (NP (NN Fig) (CD 5) (NN C)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ-1 (DT This) (VBN increased) (NN translocation)) (VP (VBD was) (ADVP (RB also)) (VP (VBN observed) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (VBG living) (ADJP (AFX non) (JJ pathogenic)) (NNP Escherichia) (NNP coli)) (NP (NN strain) (NN J53))))) (PRN (-LRB- -LRB-) (NP (NN Fig) (CD 5) (NN D)) (-RRB- -RRB-)))) (. .)) )
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ-1 (NP (NN translocation)) (PP (IN of) (NP (NNP Escherichia) (NNP coli))) (PP (IN across) (NP (NML (NML (JJ free) (HYPH -) (NN PP)) (NN ileum)) (NN mucosa)))) (VP (VBD was) (ADJP-PRD (ADJP (RB very) (JJ low)) (CONJP (CC and) (RB not)) (ADJP (RB significantly) (VBN increased) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN P)) (VP (SYM >) (NP (CD 0.05)))) (, ,) (NP (NN fig) (CD 5) (NN C)) (-RRB- -RRB-))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN translocation)) (PP (IN through) (NP (NNS PPs))) (PP (IN of) (NP (NP (NP (DT a) (ADJP (RB chemically) (VBN killed)) (NNP Staphylococcus) (NNP Aureus)) (-LRB- -LRB-) (NP (NP (NN Wood) (NN strain)) (PP (IN without) (NP (NN proteinA))))) (-RRB- -RRB-) (CC and) (NP (NNP Saccharomyces) (NNP cerevisiae))))) (VP (VBD was) (ADVP (RB also)) (ADJP-PRD (ADJP (JJR higher)) (PP-1 (-NONE- *ICH*))) (PP-LOC (IN in) (NP (NN KO))) (PP-1 (IN than) (PP-LOC (IN in) (NP (NN WT) (NNS mice)))) (PRN (-LRB- -LRB-) (NP (NN Fig) (CD 5) (NML (NN E) (CC and) (NN F))) (-RRB- -RRB-) (-RRB- -RRB-))) (. .)) )
( (S (S (NP-SBJ (NN TNBS) (NN colitis)) (VP (VBZ is) (NP-PRD (NP (DT a) (ADJP (RB well) (VBN studied)) (NN model)) (PP (IN of) (NP (JJ acute) (NN colitis))) (PP-LOC (IN in) (NP (NNS mice)))))) (CC but) (S (NP-SBJ (NP (DT no) (NNS data)) (PP-1 (-NONE- *ICH*))) (VP (VBP are) (ADVP-TMP (RB currently)) (ADJP-PRD (JJ available)) (PP (IN in) (NP (DT the) (NN literature))) (PP-1 (IN on) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN Card15) (HYPH /) (NN Nod2))) (PP (IN in) (NP (DT this) (JJ experimental) (NN model))))))) (. .)) )
( (S (S (PP-TMP (NP-ADV (CD Three) (NNS days)) (IN after) (NP (NP (JJ intracolonic) (NN instillation)) (PP (IN of) (NP (NN TNBS))))) (, ,) (NP-SBJ (DT the) (NML (NN body) (NN weight)) (NN loss)) (VP (VBD was) (ADJP-PRD (ADJP (JJR higher)) (PP-2 (-NONE- *ICH*))) (PP (IN in) (NP (NN KO) (NML-1 (-NONE- *RNR*)))) (PP-2 (IN than) (PP-LOC (IN in) (NP (NN WT) (NML-1 (-NONE- *RNR*))))) (NML-1 (NNS mice)))) (CC but) (S (NP-SBJ (DT this) (NN difference)) (VP (VBD did) (RB not) (VP (VB reach) (NP (NN significance)) (PRN (-LRB- -LRB-) (NP (NN Fig) (CD 6) (NN A)) (-RRB- -RRB-))))) (. .)) )
( (S (S (ADVP (RB Nevertheless)) (, ,) (NP-SBJ=1 (NP (DT the) (NML (JJ colonic) (JJ mucosal) (NN damage)) (NN score)) (NAC-2 (-NONE- *ICH*))) (VP (VBD was) (ADJP-PRD (JJR higher)) (PP-LOC (IN in) (NP (NN KO) (NNS mice))) (PRN (-LRB- -LRB-) (NP (NN Fig) (CD 6) (NN B)) (-RRB- -RRB-)))) (NAC-2 (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJ mucosal) (NNS concentrations)) (PP (IN of) (NP (NP (NN IL) (HYPH -) (NN 1β)) (, ,) (NP (NN TNF) (HYPH -) (NN α)) (CC and) (NP (NN IL) (HYPH -) (CD 12)))) (PRN (-LRB- -LRB-) (NP (NN Fig) (CD 6) (NN C)) (-RRB- -RRB-)))) (. .)) )
( (HEADING (NP (NN Discussion))) )
( (S (PP-TMP (IN Since) (NP (NP (DT the) (NN discovery)) (PP (IN of) (NP (NP (DT an) (NN association)) (PP (IN between) (NP (NP (NML (NN CARD15) (HYPH /) (NN NOD2)) (NNS mutations)) (CC and) (NP (CC both) (NP (NN CD) (PRN (-LRB- [) (NP (CD 1)) (-RRB- ])) (, ,) (PRN (-LRB- [) (NP (CD 2)) (-RRB- ]))) (CC and) (NP (NN GVH) (PRN (-LRB- [) (NP (CD 3)) (-RRB- ])) (, ,) (PRN (-LRB- [) (NP (CD 4)) (-RRB- ])))))))))) (, ,) (NP-SBJ-1 (NP (NP (DT the) (JJ pathophysiological) (NNS functions)) (PP (IN of) (NP (NN CARD15) (HYPH /) (NN NOD2)))) (VP (VBN involved) (NP (-NONE- *)) (PP (IN in) (NP (NML (NN CD) (CC and) (NN GVHD)) (NN development))))) (VP (VBP are) (ADVP (RB poorly)) (VP (VBN understood) (NP-1 (-NONE- *)) (PRN (-LRB- [) (NP (CD 9)) (-RRB- ])))) (. .)) )
( (S (ADVP (RB However)) (, ,) (SBAR-PRP (IN because) (S (NP-SBJ-1 (NP (NP (DT an) (NN association)) (PP (IN between) (NP (NP (NN GALT) (NNS dysfonctions)) (CC and) (NP (NN GVHD))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (ADJP (JJ spatial) (CC and) (JJ temporal)) (NNS links)) (PP (IN between) (NP (NP (NN CD) (NNS lesions)) (CC and) (NP (NNS PP)))))) (VP (VBP have) (VP (VBN been) (VP (VBN suggested) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (JJ several) (NNS authors)))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD used) (NP (NP (DT a) (JJ new) (NN model)) (PP (IN of) (NP (ADJP (NP (NN Card15) (HYPH /) (NN Nod2)) (JJ deficient)) (NN mouse)))) (, ,) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB explore) (NP (NP (DT the) (NN impact)) (PP (IN of) (NP (NN CARD15) (HYPH /) (NN NOD2))) (PP (IN in) (NP (NN PP) (NML (NN development) (CC and) (NN function))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBD observed) (SBAR (IN that) (S (NP-SBJ (JJ adult) (NN KO) (NNS mice)) (VP (VBP exhibit) (NP (NP (DT an) (NN excess)) (PP (IN of) (NP (NP (NNS PP)) (CC and) (NP (VBN isolated) (NNS LFs))))) (PP-LOC (IN in) (NP (DT the) (NN gut))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS PP)) (PP (IN from) (NP (NN KO) (NNS mice)))) (VP (VBP are) (VP (VBN characterized) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NP (DT an) (NN excess)) (PP (IN of) (NP (NP (NN M) (NNS cells)) (CC and) (NP (NML (NN CD4) (SYM +)) (NN T) (HYPH -) (NNS cells))))) (CC and) (NP (NP (DT a) (JJR higher) (NN expression)) (PP (IN of) (NP (NML (NN Th1) (CC and) (NN Th2)) (NNS cytokines)))))))) (. .)) )
( (S (NP-SBJ-1 (DT These) (NNS differences)) (VP (VBP are) (VP (VBN associated) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (VBN increased) (JJ paracellular) (NN permeability)) (CC and) (NP (NP (UCP (JJ bacterial) (CC and) (NN yeast)) (NN passage)) (PP (IN through) (NP (NNS PPs)))))))) (. .)) )
( (S (ADVP (RB Finally)) (, ,) (NP-SBJ (PRP we)) (VP (VBD observed) (SBAR (IN that) (S (NP-SBJ (ADJP (NP (NN Card15) (HYPH /) (NN Nod2)) (JJ deficient)) (NNS mice)) (VP (VBP are) (ADJP-PRD (RBR more) (JJ susceptible) (PP (IN to) (NP (ADJP (NN TNBS) (VBN induced)) (NN colitis)))))))) (. .)) )
( (S (PP (IN As) (NP (DT a) (NN whole))) (, ,) (NP-SBJ (NP (DT the) (ADJP (RB here) (VBN reported)) (NN phenotype)) (PP (IN of) (NP (DT the) (NML (NML (NN Card15) (HYPH /) (NN Nod2)) (NN KO)) (NN mouse)))) (VP (VBZ is) (ADJP-PRD (JJ reminiscent) (PP (IN to) (NP (NP (DT the) (NNS observations)) (VP (VBN made) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NP (NP (DT the) (JJ Human) (NNS diseases)) (ADJP (VBN associated) (PP (IN with) (NP (NML (NN CARD15) (HYPH /) (NN NOD2)) (NNS mutations))))) (: :) (NP (NN CD) (CC and) (NN GVHD))))))))) (. .)) )
( (S (NP-SBJ (PRP$ Our) (NNS data)) (VP (VBP demonstrate) (ADVP-TMP (RB first)) (SBAR (IN that) (S (NP-SBJ (ADJP (NP (NN Card15) (HYPH /) (NN Nod2)) (JJ deficient)) (NNS mice)) (VP (VBP have) (NP (NP (DT an) (VBN elevated) (NN number)) (PP (IN of) (NP (NP (NNS PPs)) (CC and) (NP (VBN isolated) (NNS LFs)))) (PP-TMP (IN after) (NP (NN birth)))))))) (. .)) )
( (S (SBAR-PRP (IN As) (S (NP-SBJ (JJ intestinal) (NML (NN weight) (CC and) (NN length))) (VP (VBP are) (ADJP-PRD (JJ similar) (PP (IN between) (NP (NML (NN KO) (CC and) (NN WT)) (NNS mice))))))) (, ,) (NP-SBJ-1 (DT this) (NN finding)) (VP (VBZ does) (RB not) (VP (VB seem) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (ADJP-PRD (JJ secondary) (PP (IN to) (NP (DT an) (JJ intestinal) (NN overgrowth))))))))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (NP (NNS PPs)) (PP (IN from) (NP (JJ deficient) (NNS mice)))) (VP (VBP are) (ADJP-PRD (JJR larger)) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN indicated) (NP-1 (-NONE- *)) (PP (PP (IN by) (NP-LGS (NP (DT the) (JJ macroscopic) (NN examination)) (PP (IN of) (NP (DT the) (NNS intestines))))) (CC and) (PP (IN by) (NP-LGS (NP (DT the) (NN count)) (PP (IN of) (NP (NNS PP) (NNS cells)))))))))) (. .)) )
( (S (PP (IN As) (NP (DT a) (NN result))) (, ,) (S (S (NP-SBJ (NN Card15) (HYPH /) (NN Nod2)) (VP (VBZ modulates) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (DT the) (NN GALT)))))) (CC and) (S (NP-SBJ-1 (NML (NN Card15) (HYPH /) (NN Nod2)) (NN deficiency)) (VP (VBZ is) (VP (VBN characterised) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT an) (NN overgrowth)) (PP (IN of) (NP (NP (DT the) (NN lymphoïd) (NN tissue)) (RRC (ADJP-PRD (JJ present)) (PP-LOC (IN in) (NP (DT the) (NN gut)))))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT This) (RB over) (HYPH -) (NN development)) (PP (IN of) (NP (DT the) (JJ lymphoïd) (NN tissue)))) (VP (VBZ seems) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (ADJP-PRD (JJ specific) (PP (IN to) (NP (DT the) (NN GI) (NN tract)))) (SBAR-PRP (IN as) (S (NP-SBJ-2 (ADJP (AFX non) (JJ significant)) (NN change)) (VP (VBD were) (VP (VBN observed) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT a) (JJ systemic) (JJ immune) (NN organe)) (PP (IN like) (NP (NN spleen))))))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN lack)) (PP (IN of) (NP (NP (NN difference)) (PP (IN in) (NP (NNS PP) (NN number))) (PP (IN between) (NP (NML (NN WT) (CC and) (NN KO)) (NNS mice))))) (PP-TMP (IN at) (NP (NN birth)))) (VP (VBZ indicates) (SBAR (IN that) (S (NP-SBJ (NN Card15) (HYPH /) (NN Nod2)) (VP (VBZ plays) (NP (PRP$ its) (NN role)) (PP-TMP (IN during) (NP (NP (ADJP (AFX post) (JJ natal)) (NN development)) (PP (IN of) (NP (DT the) (NN GALT))))))))) (. .)) )
( (S (SBAR-ADV (IN While) (S (NP-SBJ (NML (NML (NN lymphotoxin)) (CC and) (NML (NN IL) (HYPH -) (CD 7))) (NN signalling)) (VP (VBP are) (ADJP-PRD (JJ essential) (PP (IN for) (NP (NP (DT the) (NN organogenesis)) (PP (IN of) (NP (NNS PP))) (PP-TMP (IN during) (NP (DT the) (JJ embryonic) (NN stage)))))) (PRN (-LRB- [) (NP (CD 20)) (-RRB- ]) (PP (SYM –) (-LRB- [) (NP (CD 22))) (-RRB- ]))))) (, ,) (NP-SBJ-1 (NP (PRP it)) (SBAR-3 (-NONE- *EXP*))) (VP (VBZ is) (ADVP (RB widely)) (VP (VBN believed) (NP-1 (-NONE- *)) (SBAR-3 (IN that) (S (NP-SBJ (NN gut) (JJ commensal) (NNS bacteria)) (VP (VBP are) (ADJP-PRD (JJ critical) (PP (IN for) (NP (NP (DT the) (JJ postnatal) (NN development)) (PP (IN of) (NP (ADJP (NN gut) (JJ mucosal)) (JJ immune) (NN system))))))))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN demonstrated) (NP-2 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NNS studies)) (PP (IN on) (NP (ADJP (NN germ) (HYPH -) (JJ free)) (NNS animals)))))))) (PRN (-LRB- [) (NP (CD 23)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ (JJ Such) (NNS animals)) (VP (VP (VBP have) (NP (DT an) (VBN underdeveloped) (NN GALT))) (CC and) (VP (VBP are) (ADJP-PRD (JJ resistant) (PP (PP (IN to) (NP (JJ experimental) (NN colitis))) (CC and) (PP (IN to) (NP (JJ severe) (NN GVHD))))) (PRN (-LRB- [) (NP (CD 18)) (-RRB- ])))) (. .)) )
( (S (ADVP (RB Thereby)) (, ,) (NP-SBJ-1 (NP (NML (NN pattern) (NN recognition)) (NNS receptors)) (, ,) (PP (VBG including) (NP (NML (NNS TLRs) (CC and) (NN NOD)) (NNS molecules)))) (, ,) (VP (MD can) (VP (VB be) (VP (VBN seen) (NP-1 (-NONE- *)) (PP (IN as) (NP (NP (JJ good) (NNS candidates)) (SBAR (WHPP-2 (IN by) (WHNP (WDT which))) (S (NP-SBJ (DT the) (JJ resident) (NN flora)) (VP (VBZ stimulates) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NN GALT)))) (PP-MNR-2 (-NONE- *T*)))))))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ (NNS TLRs)) (VP (VBP play) (NP (NP (RB only) (DT a) (VBN limited) (NN role)) (PP (IN in) (NP (NN PP) (NN development))) (PP-TMP (IN at) (NP (ADJP (JJ early) (JJ postnatal)) (NN stage))) (PP-LOC (IN in) (NP (NNS mice)))) (PRN (-LRB- [) (NP (CD 24)) (-RRB- ]))) (. .)) )
( (S (PP (IN At) (NP (DT the) (JJ opposite))) (, ,) (NP-SBJ (PRP$ our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (NN Card15) (HYPH /) (NN Nod2)) (VP (VBZ plays) (NP (NP (DT a) (JJ pivotal) (NN role)) (PP (IN in) (NP (NP (DT the) (JJ postnatal) (NN development)) (PP (IN of) (NP (NN GALT)))))))))) (. .)) )
( (S (SBAR-PRP (IN Because) (S (NP-SBJ (NN gut) (NN flora)) (VP (VBZ is) (ADJP-PRD (JJ important)) (PP (IN in) (NP (NNS PP) (NN development)))))) (, ,) (NP-SBJ-2 (NP (PRP it)) (SBAR-1 (-NONE- *EXP*))) (VP (MD can) (VP (VB be) (VP (VBN questioned) (NP-2 (-NONE- *)) (SBAR-1 (IN if) (S (NP-SBJ (NML (NN Card15) (HYPH /) (NN Nod2)) (NN deficiency)) (VP (VBZ affects) (NP (NP (NML (NN gut) (NN flora)) (NN composition)) (PP (IN of) (NP (DT the) (NN host)))))))))) (. .)) )
( (S (PP-PRP (IN In) (NP (NN order) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB answer) (NP (DT this) (NN question))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD counted) (NP (NP-1 (DT the) (NNS bacteria)) (UCP (VP (ADVP (RBS most)) (VBN represented) (NP (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NN ileum)))) (CC and) (ADJP (JJ able) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB cultivate) (PP (IN in) (NP (JJ standard) (NNS conditions)))))))))) (. .)) )
( (S (NP-SBJ-1 (PRP We)) (VP (VBD failed) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB demonstrate) (NP (NP (NNS differences)) (PP (IN between) (NP (NML (NN KO) (CC and) (NN WT)) (NNS mice)))) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ (NML (NN Card15) (HYPH /) (NN Nod2)) (NN deficiency)) (VP (VBZ does) (RB not) (VP (VB induce) (NP (NP (JJ gross) (NNS abnormalities)) (PP (IN of) (NP (DT the) (NN gut) (NNS microflora)))))))))))))) (. .)) )
( (S (S (ADVP (RB However)) (, ,) (NP-SBJ-1 (ADJP (RBR more) (JJ discrete)) (NNS alterations)) (VP (MD can) (RB not) (VP (VB be) (VP (VBN discarded) (NP-1 (-NONE- *)))))) (CC and) (S (NP-SBJ-2 (NP (JJ additional) (NNS experiments)) (VP (VBG using) (NP (NP (ADJP (NN germ) (HYPH -) (JJ free)) (NNS animals)) (CONJP (CC and) (HYPH /) (CC or)) (NP (NP (JJ molecular) (NNS methods)) (PP (IN for) (NP (JJ bacterial) (NN detection))))))) (VP (VBP are) (VP (VBN required) (S (NP-SBJ-2 (-NONE- *)) (VP (TO to) (ADVP (RB further)) (VP (VB explore) (NP (NP (DT the) (NN relationship)) (PP (IN between) (NP (NP (NN Card15) (HYPH /) (NN Nod2)) (CC and) (NP (DT the) (JJ normal) (NN gut) (NNS flora))))))))))) (. .)) )
( (S (NP-SBJ (NNS PPs)) (VP (VBP have) (NP (NP (NML (NN B) (HYPH -) (NN cell)) (NNS follicles)) (CC and) (NP (NP (JJ germinal) (NNS centres)) (VP (VBN surrounded) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (NNS areas)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP contain) (ADVP (RB predominantly)) (NP (NN T) (NNS cells))))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NN analysis)) (PP (IN of) (NP (DT the) (NNS PP))) (PP (IN from) (NP (ADJP (NP (NN Card15) (HYPH /) (NN Nod2)) (JJ deficient)) (NNS mice)))) (VP (VBD failed) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB reveal) (NP (NP (JJ gross) (NNS abnormalities)) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NP (NP (NN microachitecture)) (, ,) (NP (NN apoptosis)) (CC or) (NP (NN cell) (NN composition))) (-LRB- -LRB-) (PP (ADVP (RB at) (RBS least)) (IN for) (NP (NP (NP (DT the) (CD three) (JJ main) (NN cell) (NNS lineages)) (ADJP (JJ present) (PP-LOC (IN in) (NP (NNS PP))))) (, ,) (NP (ADVP (RB namely)) (NP (NN B) (HYPH -) (NNS cells)) (, ,) (NP (NN T) (HYPH -) (NNS cells)) (CC and) (NP (JJ dendritic) (NNS cells)))))) (-RRB- -RRB-))))))))) (. .)) )
( (S (NP-SBJ (DT This) (NN observation)) (VP (VBZ is) (PP-PRD (IN in) (NP (NP (NN accordance)) (PP (IN with) (NP (NP (DT the) (JJ previous) (NNS descriptions)) (PP (IN of) (NP (NP (NP (JJ other) (NML (NML (NN Card15) (HYPH /) (NN Nod2)) (NN KO)) (NNS models)) (PP (IN of) (NP (NNS mice)))) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD failed) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB reveal) (NP (JJ gross) (JJ intestinal) (NNS abnormalities)) (PP (IN under) (NP (JJ basal) (NNS conditions))))))))))))))) (PRN (-LRB- [) (NP (CD 7)) (-RRB- ])) (, ,) (PRN (-LRB- [) (NP (CD 25)) (-RRB- ]))) (. .)) )
( (S (ADVP (RB Interestingly)) (, ,) (NP-SBJ (NP (DT the) (NN phenotype)) (VP (VBN observed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (JJ deficient) (NN mouse))))) (VP (VBZ is) (ADJP-PRD (JJ reminiscent) (PP (IN with) (NP (NP (DT the) (JJ Human) (NN CD) (NN condition)) (SBAR (WHADVP-2 (WRB where)) (S (NP-SBJ-1 (NP (JJ large) (JJ lymphoid) (NNS aggregates)) (PP (IN with) (NP (JJ normal) (NML (NML (NN microarchitecture)) (CC and) (NML (NN cell) (NN composition)))))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (NP-1 (-NONE- *)) (ADVP-LOC-2 (-NONE- *T*)) (PRN (-LRB- [) (NP (CD 26)) (-RRB- ]))))))))))) (. .)) )
( (S (NP-SBJ-1 (NNS LFs)) (VP (VBP are) (VP (VBN covered) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT a) (VBN specialised) (NN epithelium)) (PP (VBG including) (NP (NN M) (NNS cells))))))) (. .)) )
( (S (NP-SBJ-1 (DT These) (NNS cells)) (VP (VBP are) (ADJP-PRD (JJ able) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB transfer) (NP (UCP (JJ bacterial) (CC and) (NN food)) (NNS antigens)) (PP (PP (IN from) (NP (DT the) (NN gut) (NN lumen))) (PP (IN to) (NP (ADJP (NN antigen) (VBG presenting)) (NNS cells)))) (PRN (-LRB- [) (NP (CD 23)) (-RRB- ]))))))) (. .)) )
( (S (NP-SBJ (PRP They)) (VP (VBP have) (ADVP (RB thus)) (NP (NP (DT a) (JJ pivotal) (NN role)) (PP (IN in) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (NNS PP))))))) (. .)) )
( (S (NP-SBJ-1 (NN M) (NNS cells)) (VP (VBD were) (VP (VBN found) (S (NP-SBJ-1 (-NONE- *)) (ADJP-PRD (RBR more) (JJ numerous))) (PP-LOC (IN in) (NP (NN KO) (NNS mice))))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (NP (NNS PP)) (PP (IN of) (NP (NN KO) (NNS mice)))) (VP (VBD exhibited) (NP (NP (NP (DT a) (JJR higher) (NN proportion)) (PP (IN of) (NP (NML (NN CD4) (SYM +)) (NN T) (HYPH -) (NNS cells)))) (CC and) (NP (NP (DT a) (VBN decreased) (NN percentage)) (PP (IN of) (NP (NML (NN CD3) (SYM +)) (NML (NN CD8) (SYM −)) (NML (NN CD4) (SYM −)) (NN T) (HYPH -) (NNS cells)))))) (. .)) )
( (S (SBAR-PRP (IN As) (S (NP-SBJ (NN Nod2)) (VP (MD may) (VP (VB modulate) (NP (DT the) (NN apoptosis)))))) (, ,) (NP-SBJ (PRP we)) (VP (VBP have) (VP (VBN hypothesized) (SBAR (IN that) (S (NP-SBJ (NP (DT this) (NN increase)) (PP (IN of) (NP (NML (NML (NN CD4) (SYM +)) (NN T) (HYPH -) (NN cell)) (NN number)))) (VP (MD may) (VP (VB result) (PP (IN from) (NP (NP (DT an) (NN apoptosis) (NN defect)) (PP-LOC (IN in) (NP (NP (DT the) (JJ lymphoid) (NNS cells)) (PP (IN of) (NP (NN KO) (NNS mice))))))))))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ (NML (NN flow) (NN cytometry)) (NNS analyses)) (VP (VBD revealed) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (JJ relative) (NN proportion)) (PP (IN of) (NP (NP (JJ apoptotic) (NML (NN CD4) (SYM +)) (NN T) (HYPH -) (NNS cells)) (PP (IN from) (NP (NNS PP)))))) (VP (VBD was) (ADJP-PRD (JJ similar)) (PP (IN between) (NP (NML (NN KO) (CC and) (NN WT)) (NNS mice))))))) (. .)) )
( (S (PP (IN As) (NP (DT a) (NN result))) (, ,) (NP-SBJ (PRP$ our) (NNS experiments)) (VP (VBP do) (RB not) (VP (VB support) (NP (DT the) (NN opinion) (SBAR (IN that) (S (NP-SBJ-1 (NML (NN Card15) (HYPH /) (NN Nod2)) (NN deficiency)) (VP (VBZ is) (VP (VBN characterised) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (DT a) (JJ general) (NN apoptosis) (NN defect))) (PP-LOC (IN in) (NP (NP (DT the) (JJ lymphoid) (NN tissue)) (PP (IN of) (NP (NN KO) (NNS mice)))))))))))) (. .)) )
( (S (ADVP (RB Finally)) (, ,) (NP-SBJ (DT the) (VBN altered) (NML (JJ immune) (NN cell)) (NN composition)) (VP (VBZ is) (ADJP-PRD (JJ concomitant) (PP (IN with) (NP (NP (DT an) (NN increase)) (PP (IN of) (NP (NML (NML (JJ pro-inflammatory) (NN Th1)) (CONJP (CC but) (RB also)) (NML (JJ anti-inflammatory) (NN Th2))) (NN cytokine) (NN expression))))))) (. .)) )
( (S (ADVP (RB Altogether)) (, ,) (NP-SBJ (DT these) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (PP (IN under) (NP (JJ basal) (NN condition))) (, ,) (NP-SBJ-1 (NP (NNS PPs)) (PP (IN of) (NP (NN KO) (NNS mice)))) (VP (VBP are) (VP (VBN characterised) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (DT an) (VBN exaggerated) (JJ immune) (NN response)))))))) (. .)) )
( (S (NP-SBJ (NP (NN Cell) (NN composition)) (CC and) (NP (NN cytokine) (NN production))) (VP (MD may) (VP (VB affect) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (NNS PP)))))) (. .)) )
( (S (NP-SBJ (PRP We)) (ADVP (RB thus)) (VP (VBD used) (NP (NNP Ussing) (NNS chambers)) (PP-PRP (IN for) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG determining) (NP (DT the) (JJ paracellular) (NN permeability)) (PP-MNR (IN through) (NP (NP (NNS PP)) (CC and) (NP (ADJP (NNS PP) (HYPH -) (JJ free)) (NN ileum)))))))) (. .)) )
( (S (NP-SBJ (NN KO) (NNS mice)) (VP (VBD exhibited) (NP (NP (DT a) (JJ significant) (NN increase)) (PP (IN of) (NP (JJ paracellular) (NN permeability))))) (. .)) )
( (S (NP-SBJ (DT This) (NN result)) (VP (VBZ is) (PP-PRD (IN in) (NP (NP (NN accordance)) (PP (IN with) (NP (NP (DT the) (VBN altered) (JJ intestinal) (NN permeability)) (VP (VBN reported) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NP (NN CD) (NNS patients)) (CC and) (NP (PRP$ their) (JJ healthy) (NNS relatives)))) (, ,) (PP (ADVP (RB especially)) (IN in) (NP (NP (NN case)) (PP (IN of) (NP (NML (NN CARD15) (HYPH /) (NN NOD2)) (NNS mutations))))) (PRN (-LRB- [) (NP (NP (CD 27)) (-RRB- ]) (PP (SYM –) (-LRB- [) (NP (CD 30)))) (-RRB- ])))))))) (. .)) )
( (S (NP-SBJ-1 (ADJP (AFX Pro) (HYPH -) (CC and) (JJ anti-inflammatory)) (NNS cytokines)) (VP (VBP are) (VP (VBN known) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB modulate) (NP (JJ intestinal) (JJ paracellular) (NN permeability))))))) (. .)) )
( (S (NP-SBJ (NP (NN IFNγ)) (, ,) (NP (NN TNFα)) (CC and) (NP (NN IL) (HYPH -) (CD 4))) (, ,) (VP (VBP act) (PP (IN on) (NP (NP (NN membrane) (NNS receptors)) (PP (IN of) (NP (JJ epithelial) (NNS cells))))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB increase) (NP (JJ tight) (NN junction) (NN permeability))))) (PRN (-LRB- [) (NP (NP (CD 31)) (-RRB- ]) (PP (SYM –) (-LRB- [) (NP (CD 34)))) (-RRB- ]))) (. .)) )
( (S (PP (IN For) (NP (NN example))) (, ,) (PP-LOC (IN on) (NP (NN T84) (NNS cells))) (NP-SBJ (NN IFNγ)) (VP (VP (VBD decreased) (NP (NP (NNS levels)) (PP (IN of) (NP (NN ZO) (HYPH -) (CD 1))))) (CC and) (VP (VBD altered) (NP (NP (JJ apical) (NN actin) (NN organisation)) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ leads) (PP (IN to) (NP (NP (NP (NN disorganisation)) (PP (IN of) (NP (NN TJ)))) (CC and) (NP (VBN increased) (NN permeability))))))))) (PRN (-LRB- [) (NP (CD 35)) (-RRB- ]))) (. .)) )
( (S (ADVP (RB Similarly)) (, ,) (NP-SBJ (NP (NNS PP)) (PP (IN from) (NP (NN KO) (NNS mice)))) (VP (VBD exhibited) (NP (NP (DT a) (NN decrease)) (PP (IN of) (NP (NML (NML (NN ZO) (HYPH -) (CD 1)) (CC and) (NML (NN ZO) (HYPH -) (CD 2))) (NN mRNA) (NN expression)))) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (NN WT) (NNS mice)))))) (. .)) )
( (S (ADVP (RB Consequently)) (, ,) (NP-SBJ (NP (NP (DT the) (JJ excessive) (NN concentration)) (PP (IN of) (NP (NN IFNγ)))) (VP (VBN observed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NN KO) (NNS mice))))) (VP (MD may) (VP (VP (RB down) (VB regulate) (NP (NP (DT the) (NN transcription)) (PP (IN of) (NP (NML (NML (NN ZO) (HYPH -) (CD 1)) (CC and) (NML (NN ZO) (HYPH -) (CD 2))) (NN mRNA) (NN expression))))) (CC and) (VP (VBP contribute) (PP (IN to) (NP (NP (DT the) (VBN increase) (JJ paracellular) (NN permeability)) (PP-LOC (IN in) (NP (NN KO) (NNS mice)))))))) (. .)) )
( (S (NP-SBJ (PRP It)) (VP (VBZ is) (S-PRD (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB note) (SBAR (IN that) (S (NP-SBJ (DT this) (NN phenotype)) (VP (VBZ is) (ADJP-PRD (JJ reminiscent) (PP (IN to) (NP (DT the) (ADJP (NP (NN CARD15) (HYPH /) (NN NOD2)) (VBN associated)) (JJ Human) (NNS disorders))))))))))) (. .)) )
( (S (ADVP (RB Indeed)) (, ,) (PP-LOC (IN in) (NP (NN CD) (NNS patients))) (, ,) (NP-SBJ-1 (VBN increased) (NN permeability)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (NP-SBJ-1 (-NONE- *)) (VP (VP (TO to) (VP (VB be) (VP (VBN mediated) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NN TNFα)))))) (CC and) (VP (TO to) (VP (VB precede) (NP (DT the) (JJ clinical) (NN relapse)))))) (SBAR-ADV (IN while) (S (NP-SBJ-2 (NN GVHD)) (VP (VBZ has) (VP (VBN been) (VP (VBN treated) (NP-2 (-NONE- *)) (PP (IN by) (NP-LGS (JJ anti-TNF) (NNS antibodies)))))))) (PRN (-LRB- [) (NP (CD 36)) (-RRB- ])) (, ,) (PRN (-LRB- [) (NP (CD 37)) (-RRB- ]))))) (. .)) )
( (S (PP-PRP (IN Because) (IN of) (NP (NP (DT the) (NNS changes)) (PP (IN in) (NP (NN gut) (NN permeability))))) (, ,) (NP-SBJ (PRP we)) (ADVP-TMP (RB finally)) (VP (VBD studied) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN Card15) (HYPH /) (NN Nod2))) (PP (IN in) (NP (JJ bacterial) (NN translocation))))) (. .)) )
( (S (NP-SBJ (NP (NP (JJ Bacterial) (NN passage)) (PP (IN of) (NP (NP (NNP Staphylococcus) (NNP aureus)) (CC and) (NP (NNP Escherichia) (NNP coli)))) (PP-1 (-NONE- *RNR*))) (CC and) (NP (NP (NN yeast) (NN ingress)) (PP (IN of) (NP (NNP Saccharomyces) (NNP cerevisiae))) (PP-1 (-NONE- *RNR*)))) (VP (VBD were) (ADJP-PRD (JJR higher)) (PP-1 (IN through) (NP (NP (NNS PP)) (PP (IN of) (NP (NN KO) (NNS mice)))))) (. .)) )
( (S (NP-SBJ-1 (NP (PRP It)) (SBAR-2 (-NONE- *EXP*))) (VP (VBZ is) (ADVP (RB widely)) (VP (VBN accepted) (NP-1 (-NONE- *)) (SBAR-2 (IN that) (S (NP-SBJ-4 (NN CD)) (VP (VBZ is) (VP (VBN related) (NP-4 (-NONE- *)) (PP (IN with) (NP (NP (DT an) (JJ excessive) (JJ bacterial) (NN translocation)) (PP (IN through) (NP (DT the) (JJ intestinal) (NN epithelium))))) (SBAR-ADV (RB even) (IN if) (S (NP-SBJ-3 (DT this) (NN hypothesis)) (VP (VBZ is) (RB not) (ADVP (RB perfectly)) (VP (VBN documented) (NP-3 (-NONE- *)))))))))))) (. .)) )
( (S (NP-SBJ (DT The) (JJ present) (NNS data)) (ADVP (RB further)) (VP (VBP support) (NP (DT this) (NN opinion))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (NP (DT this) (NN excess)) (PP (IN of) (NP (NP (NML (NN yeast) (CC and) (NNS bacteria)) (NN translocation)) (PP (IN through) (NP (NP (NN PP)) (PP (IN of) (NP (NN KO) (NNS mice)))))))) (VP (VBZ is) (PP-PRD (IN in) (NP (NP (NN agreement)) (PP (IN with) (NP (NP (JJ recent) (NNS reports)) (VP (VBG showing) (SBAR (IN that) (S (NP-SBJ (NP (VBN mutated) (NN CD) (NNS patients)) (CC and) (NP (PRP$ their) (JJ unaffected) (NNS relatives))) (VP (VBP develop) (ADVP-TMP (RBR more) (RB frequently)) (NP (NP (NNS antibodies)) (PP (IN to) (NP (NP (NNP Saccharomyces) (NNP cerevisiae)) (, ,) (NP (ADJP (NP (NNP Pseudomonas) (NNP fluorescens)) (HYPH –) (VBN related)) (NN protein)) (, ,) (NP (NP (NNP Escherichia) (NNP coli)) (JJ outer) (NN membrane) (NN porin) (NN C)) (CC and) (NP (NN CBir1) (NN flagellin))))) (PRN (-LRB- [) (NP (CD 38)) (-RRB- ]))))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (JJ excessive) (NML (NNS bacteria) (CC and) (NN yeast)) (NN passage)) (VP (VBN reported) (NP (-NONE- *)) (ADVP (RB here)))) (VP (MD may) (VP (VB participate) (PP (IN in) (NP (NP (DT the) (NN enhancement)) (PP (IN of) (NP (NP (JJ adaptive) (JJ immune) (NNS responses)) (PP (IN to) (NP (JJ microbial) (NNS antigens))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (VBN increased) (NN number)) (PP (IN of) (NP (NN M) (NNS cells)))) (VP (MD can) (VP (VB contribute) (PP (IN to) (NP (NP (DT the) (JJ high) (NN translocation) (NN rate)) (VP (VBN observed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NN KO) (NNS mice)))))))) (. .)) )
( (S (S (ADVP (RB However)) (, ,) (SBAR-PRP (IN because) (S (NP-SBJ (NML (NN M) (NN cell)) (NN differentiation)) (VP (VBZ is) (ADJP-PRD (JJ inducible)) (PP-MNR (IN by) (NP (JJ microbial) (NN challenge))) (PRN (-LRB- [) (NP (CD 39)) (-RRB- ]))))) (, ,) (NP-SBJ (PRP it)) (VP (MD may) (ADVP (RB also)) (VP (VB be) (NP-PRD (NP (DT a) (NN consequence)) (PP (IN of) (NP (JJ bacterial) (NNS translocations))))))) (CC and) (S (NP-SBJ-1 (JJ additional) (NNS experiments)) (VP (VBP are) (VP (VBN required) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (ADVP (RB further)) (VP (VB dissect) (NP (DT this) (JJ complex) (NN relationship)))))))) (. .)) )
( (S (NP-SBJ (NP (PRP It)) (S-1 (-NONE- *EXP*))) (VP (VBZ is) (ADVP (RB also)) (ADJP-PRD (JJ possible)) (S-1 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB consider) (SBAR (IN that) (S (NP-SBJ (NML (NN CARD15) (HYPH /) (NN NOD2)) (NN dysfunction)) (VP (VBZ facilitates) (NP (NP (JJ bacterial) (NN entry)) (PP (IN through) (NP (NP (JJ defective) (NML (JJ antibacterial) (NN peptide)) (NN expression) (PRN (-LRB- [) (NP (CD 7)) (-RRB- ]))) (, ,) (NP (VBN impaired) (JJ intracellular) (JJ bactericidal) (NN capacity)) (CC or) (NP (VBN reduced) (JJ epithelial) (JJ immune) (NN defence)))))))))))) (. .)) )
( (S (ADVP (RB Finally)) (, ,) (NP-SBJ (JJ bacterial) (NN translocation)) (VP (MD may) (ADVP (RB also)) (VP (VB be) (ADJP-PRD (JJ secondary) (PP (IN to) (NP (JJ primitive) (NML (JJ local) (NN cytokine)) (NNS changes)))))) (. .)) )
( (S (NP-SBJ-1 (NN IFNγ)) (VP (VBZ is) (VP (VBN known) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB increase) (NP (NP (DT the) (JJ epithelial) (NN adherence)) (PP (IN of) (NP (NP (VBN selected) (NNS species)) (PP (IN of) (NP (JJ enteric) (NNS bacteria)))))) (PRN (-LRB- [) (NP (CD 40)) (-RRB- ]))))))) (. .)) )
( (S (NP-SBJ (NP (NNP Ferrier)) (ADVP-ETC (FW et) (FW al.))) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP-SBJ (NP (DT a) (JJ chronic) (NN stress)) (PP-LOC (IN in) (NP (NNS mice)))) (VP (VBZ drives) (NP (NP (DT an) (ADJP (NN organ) (HYPH -) (JJ specific)) (NML (NN cytokine) (NN expression)) (NN pattern)) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (PP (IN in) (NP (NN turn))) (, ,) (VP (VP (VBZ alters) (NP (DT the) (NML (JJ colonic) (JJ mucosal) (NN barrier)) (NNS functions))) (CC and) (VP (VBZ favours) (NP (JJ bacterial) (NN translocation)))))))))) (PRN (-LRB- [) (NP (CD 31)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ (DT This) (NN effect)) (VP (VP (VBZ is) (ADJP-PRD (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NML (NN CD4) (SYM +)) (NN T) (HYPH -) (NNS cells))))))) (CC and) (VP (VBZ requires) (NP (NN IFNγ) (NN production)))) (. .)) )
( (S (S (NP-SBJ (NP (PRP It)) (SBAR-1 (-NONE- *EXP*))) (VP (VBZ is) (RB thus) (ADJP-PRD (JJ possible)) (SBAR-1 (IN that) (S (NP-SBJ (JJ bacterial) (NN translocation)) (VP (VBZ is) (NP-PRD (NP (NP (DT a) (NN result)) (PP (IN of) (NP (DT the) (JJ immune) (NNS changes)))) (CONJP (RB rather) (IN than)) (NP (PRP$ its) (NN cause)))))))) (CC and) (S (NP-SBJ-2 (JJ additional) (NNS experiments)) (VP (VBP are) (ADVP-TMP (RB now)) (VP (VBN required) (NP-2 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB answer) (NP (DT this) (NN question)))))))) (. .)) )
( (S (ADVP (RB Finally)) (, ,) (NP-SBJ (PRP we)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP-SBJ (NML (NN Card15) (HYPH /) (NN Nod2)) (NN invalidation)) (VP (VBZ exacerbates) (NP (NP (DT the) (NN severity)) (PP (IN of) (NP (ADJP (NN TNBS) (VBN induced)) (NN colitis)))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN evidenced) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT the) (NN increase)) (PP (IN in) (NP (NP (NP (DT all) (NNS parameters)) (VP (VBG characterising) (NP (JJ colonic) (NN inflammation)))) (NP (-LRB- -LRB-) (NP (NP (NNS damages) (NNS scores)) (CC and) (NP (JJ mucosal) (NNS levels))) (PP (IN of) (NP (NP (NN IL) (HYPH -) (NN 1β)) (, ,) (NP (NN TNFα)) (CC and) (NP (NN IL) (HYPH -) (CD 12))))))))))))))))) (-RRB- -RRB-) (. .)) )
( (S (NP-SBJ-1 (NP (DT This) (VBN enhanced) (NN colitis)) (: -) (VP (VBN induced) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NN TNBS))))) (VP (MD might) (VP (VB be) (VP (VBN explained) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (JJ different) (NNS mechanisms)))))) (. .)) )
( (S (ADVP (RB Firstly)) (, ,) (SBAR-PRP (SBAR (IN since) (S (NP-SBJ-3 (NN microflora)) (VP (VBZ is) (VP (VBN required) (NP-3 (-NONE- *)) (PP (IN for) (NP (ADJP (NN TNBS) (HYPH -) (VBN induced)) (ADJP (JJ colonic) (JJ mucosal)) (NNS damages))))))) (CC and) (SBAR (IN since) (S (NP-SBJ-1 (NML (NN Card15) (HYPH /) (NN Nod2)) (NN signaling)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB inhibit) (NP (NP (DT the) (ADJP (NN TLR2) (HYPH -) (VBN driven)) (NN activation)) (PP (IN of) (NP (NN Th1) (NN response)))) (PRN (-LRB- [) (NP (CD 8)) (-RRB- ]))))))))))) (, ,) (NP-SBJ (PRP one)) (VP (MD can) (VP (VB hypothesize) (SBAR (IN that) (S (NP-SBJ-2 (NP (DT the) (NN Th1) (JJ inflammatory) (NN response)) (VP (VBN mediated) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NN TLR) (HYPH -) (CD 2))))) (VP (VBZ is) (VP (VBN increased) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (ADJP (NP (NN Card15) (HYPH /) (NN Nod2)) (JJ deficient)) (NNS mice))))))))) (. .)) )
( (S (ADVP (RB Secondly)) (, ,) (SBAR-PRP (IN since) (S (NP-SBJ-1 (NN GALT)) (VP (VBZ is) (VP (VBN reported) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB modulate) (NP (NP (DT the) (NN severity)) (PP (IN of) (NP (ADJP (NN TNBS) (HYPH -) (VBN induced)) (NN colitis)))) (PRN (-LRB- [) (NP (CD 41)) (-RRB- ])) (, ,) (PRN (-LRB- [) (NP (CD 42)) (-RRB- ]))))))))) (NP-SBJ-2 (NP (PRP it)) (SBAR-3 (-NONE- *EXP*))) (VP (MD can) (VP (VB be) (VP (VBN hypothesised) (NP-2 (-NONE- *)) (SBAR-3 (IN that) (S (NP-SBJ-4 (DT the) (ADJP (NN TNBS) (VBN induced)) (NN colitis)) (VP (VBZ is) (VP (VBN exacerbated) (NP-4 (-NONE- *)) (PP-LOC (IN in) (NP (NML (NML (NN Card15) (HYPH /) (NN Nod2)) (NN KO)) (NNS mice))) (PP-PRP (IN because) (IN of) (NP (NN GALT) (NN overdevelopment)))))))))) (. .)) )
( (S (ADVP (RB Finally)) (, ,) (NP-SBJ (DT an) (JJ alternative) (NN explanation)) (VP (MD could) (VP (VB be) (SBAR-PRD (IN that) (S (NP-SBJ (NP (DT the) (VBN observed) (NN defect)) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NP (JJ intestinal) (NN permeability)) (CC and) (NP (JJ bacterial) (NN translocation))))))) (VP (VBZ makes) (S (NP-SBJ (DT the) (NN intestine)) (ADJP-PRD (RBR more) (JJ susceptible) (PP (IN to) (NP (NN TNBS)))))))))) (. .)) )
( (S (ADVP (RB Altogether)) (, ,) (NP-SBJ (DT the) (JJ present) (NNS data)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP-SBJ-1 (NN Card15) (HYPH /) (NN Nod2)) (VP (VBZ is) (VP (VBN required) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB maintain) (NP (NP (DT the) (NN homeostatis)) (PP (IN of) (NP (DT the) (NNS PPs)))))))))))) (. .)) )
( (S (SBAR-PRP (IN Because) (S (NP-SBJ (NN CARD15) (HYPH /) (NN NOD2)) (VP (VBZ is) (NP-PRD (NP (DT a) (ADJP (RB well) (VBN demonstrated)) (JJ etiological) (NN factor)) (PP (IN for) (NP (NN CD) (HYPH /) (NN GVHD))))))) (, ,) (NP-SBJ (DT this) (NN conclusion)) (VP (VBZ is) (PP-PRD (IN of) (NP (NP (JJ particular) (NN importance)) (PP (IN for) (NP (NP (DT the) (NN understanding)) (PP (IN of) (NP (NN disease) (NNS mechanisms)))))))) (. .)) )
( (S (ADVP (RB Indeed)) (, ,) (NP-SBJ (PRP it)) (ADVP (RB further)) (VP (VBZ supports) (NP (DT the) (NN opinion) (SBAR (IN that) (S (NP-SBJ-1 (NP (DT the) (NN defect)) (VP (VBN involved) (NP (-NONE- *)) (PP (IN in) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (DT the) (NN gut) (NNS lesions))))))) (VP (VBZ is) (VP (VBN related) (NP-1 (-NONE- *)) (PP (IN with) (NP (NML (NNS PP) (CC and) (NN LF)) (NN function))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NN GALT) (NN dysfunction)) (VP (VBN observed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NN KO) (NNS mice))))) (VP (VBZ is) (VP (VBN associated) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (DT an) (JJ excessive) (NML (NN gut) (JJ immune)) (NN response)) (CC and) (NP (DT an) (VBN increased) (JJ bacterial) (NN translocation)))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS findings)) (VP (VBP are) (ADJP-PRD (JJ consistent) (PP (IN with) (NP (NP (PRP$ our) (NN knowledge)) (PP (IN on) (NP (NP (NP (NP (DT the) (JJ Human) (NNS diseases)) (ADJP (VBN associated) (PP (IN with) (NP (NML (NN CARD15) (HYPH /) (NN NOD2)) (NNS mutations))))) (NP (ADVP (RB namely)) (NN GVHD) (CC and) (NN CD))) (NAC (CC and) (SBAR (WHPP-2 (IN for) (WHNP (WDT which))) (S (NP-SBJ-1 (JJ similar) (NNS observations)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (NP-1 (-NONE- *)) (PP-PRP-2 (-NONE- *T*)))))))))))))) (. .)) )
( (S (PP (IN As) (NP (DT a) (NN result))) (, ,) (NP-SBJ-1 (NP (DT the) (NN phenotype)) (PP (IN of) (NP (DT the) (NML (NML (NN Card15) (HYPH /) (NN Nod2)) (NN KO)) (NNS mice)))) (VP (MD can) (VP (VB be) (VP (VBN seen) (NP-1 (-NONE- *)) (PP (IN as) (NP (NP (DT an) (VBN attenuated) (NN model)) (PP (IN of) (NP (NN CD) (HYPH /) (NN GVHD)))))))) (. .)) )
( (S (NP-SBJ (NP (PRP It)) (SBAR-3 (-NONE- *EXP*))) (VP (VBZ is) (S-PRD (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB note) (SBAR-3 (IN that) (S (NP-SBJ (NP (DT the) (NN absence)) (PP (IN of) (NP (DT a) (JJ full) (NN phenotype)))) (VP (VBZ is) (RB not) (ADJP-PRD (JJ unexpected)) (PP (VBG considering) (NP (NP (DT the) (JJ multifactorial) (NN nature)) (PP (IN of) (NP (NP (DT the) (JJ Human) (NNS diseases)) (SBAR (WHADVP-2 (WRB where)) (S (NP-SBJ-1 (NP (NN exposure)) (PP (IN to) (NP (JJ several) (JJ additional) (JJ unknown) (ADJP (JJ genetic) (CC and) (JJ environmental)) (NN risk) (NNS factors)))) (VP (VBZ is) (VP (VBN required) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NN disease) (NN expression))) (ADVP-LOC-2 (-NONE- *T*))))))))))))))))) (. .)) )
( (S (PP (IN At) (NP (DT the) (JJ opposite))) (, ,) (NP-SBJ (PRP$ our) (NN work)) (VP (VBZ indicates) (SBAR (IN that) (S (NP-SBJ (DT the) (NML (NML (NN Card15) (HYPH /) (NN Nod2)) (NN KO)) (NN mouse)) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ relevant) (NN model)) (PP (IN for) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG investigating) (NP (NP (DT these) (JJ other) (NN risk) (NNS factors)) (ADJP (VBN associated) (PP (IN with) (NP (NN CD) (CC and) (NN GVHD))))))))))))) (. .)) )
( (HEADING (NP (NN Material) (CC and) (NNS Methods))) )
( (HEADING (NP (NNS Animals))) )
( (S (NP-SBJ-1 (NN Card15) (HYPH /) (NN Nod2)) (VP (VBD was) (VP (VBN disrupted) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NNS mice))) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG replacing) (NP (NP (DT the) (JJ first) (NN coding) (NN exon)) (VP (VBG carrying) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NP (DT the) (NN sequence)) (VP (VBG encoding) (NP (DT the) (NN CARD) (NNS domains))))) (PP (VBG including) (NP (NP (DT the) (NN start) (NN codon)) (PP (IN with) (NP (DT a) (NN EGFP) (NN cassette))))))))))))) (. .)) )
( (NP (-LRB- -LRB-) (NN Fig.) (CD 7) (NN A) (-RRB- -RRB-) (. .)) )
( (S (PP (IN In) (NP (NP (DT the) (JJ first) (NN step)) (PP (IN of) (NP (DT the) (NN strategy))))) (, ,) (NP-SBJ-1 (DT the) (NML (NN Card15) (HYPH /) (NN Nod2)) (NN locus)) (VP (VBD was) (VP (VBN targeted) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (DT the) (NML (NML (NN Card15) (HYPH /) (NN Nod2)) (NN KO)) (NN targeting) (NN fragment))))) (. .)) )
( (S (PP (IN In) (NP (DT the) (JJ second) (NN step))) (, ,) (NP-SBJ-1 (DT the) (NN PGKHygromycin) (NN selection) (NN cassette)) (VP (VBD was) (VP (VBN removed) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NN Cre) (NN recombinase))))) (. .)) )
( (S (NP-SBJ-1 (VBN Targeted) (NN disruption)) (VP (VBD was) (VP (VBN determined) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NML (NML (NNP Southern) (NN blot)) (CC and) (NML (JJ long) (HYPH -) (NN range) (NN PCR))) (NN analysis))) (PRN (-LRB- -LRB-) (NP (NP (NN Fig.) (CD 7) (NN B)) (PP (SYM –) (NP (NN C)))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (NP (JJ Genomic) (NN DNA)) (PP (IN from) (NP (NNS mice)))) (VP (VBD was) (VP (VBN amplified) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN PCR))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VP (VBG using) (NP=2 (NP (DT the) (NNS primers)) (: :) (NP (NP (CD 5) (HYPH -) (NN GTCATTTCCTGACCTCTGACC) (HYPH -) (CD 3)) (CC and) (NP (CD 5) (HYPH -) (NN AACCGCATTATTCCATGGGGC) (HYPH -) (CD 3)))) (S-PRP=3 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB detect) (NP (NN WT) (NN DNA)))))) (CC and) (VP (NP=2 (NP (NNS primers)) (NP (NP (CD 5) (HYPH -) (NN AACCGCATTATTCCATGGGGC) (HYPH -) (CD 3)) (CC and) (NP (CD 5) (HYPH -) (NN GCCTGCTCTTTACTGAAGGCTC) (HYPH -) (CD 3)))) (S-PRP=3 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB detect) (NP (DT the) (VBN disrupted) (NN sequence)))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NN loss)) (PP (IN of) (NP (NML (NN mRNA) (NN Nod2)) (NN expression)))) (VP (VBD was) (VP (VBN demonstrated) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NNS splenocytes))) (PP-MNR (IN by) (NP (NN RT) (HYPH -) (NN PCR) (PRN (-LRB- -LRB-) (NP (NN Fig.) (CD 7) (NN D)) (-RRB- -RRB-)))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (DT the) (VBG following) (NNS primers)) (: :) (-LRB- -LRB-) (NP (NP (CD 5) (HYPH -) (NN CTTTGAACTGTATGGGTCC) (HYPH -) (CD 3)) (CC and) (NP (CD 5) (HYPH -) (NN CTCCACTGCCTCTGCCTTA) (HYPH -) (CD 3)))))))) (-RRB- -RRB-) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN expected) (NP-1 (-NONE- *))))) (, ,) (NP-SBJ-2 (DT no) (NN signal)) (VP (VBD was) (VP (VBN observed) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (NN KO) (NNS mice))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NML (NML (NML (NN Card15) (HYPH /) (NN Nod2)) (SYM −) (HYPH /) (SYM −)) (-LRB- -LRB-) (NML (NN KO))) (-RRB- -RRB-) (NNS mice)) (VP (VBN used) (NP (-NONE- *)) (PP-PRP (IN for) (NP (DT this) (NN study))))) (VP (VBD were) (VP (RB back) (HYPH -) (VBN crossed) (NP-1 (-NONE- *)) (NP-TMP (CD five) (NNS times)) (PP (IN with) (NP (NP (DT the) (JJ inbred) (NNS strains)) (NP (NN C57BL) (HYPH /) (CD 6)))))) (. .)) )
( (S (NP-SBJ-1 (NML (NN WT) (CC and) (NN KO)) (NNS mice)) (VP (VBD were) (VP (VBN housed) (CC and) (VBN generated) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT the) (NN animal) (NN facility)) (PP-LOC (IN at) (NP (NP (NNP Robert) (NNP Debré) (NNP Hospital)) (, ,) (NP-LOC (NNP Paris)) (, ,) (NP-LOC (NNP France)))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NN absence)) (PP (IN of) (NP (NNS enteropathogens)))) (VP (VBD was) (VP (VBN monitored) (NP-1 (-NONE- *)))) (. .)) )
( (S (NP-SBJ-1 (DT All) (NNS experiments)) (VP (VBD were) (VP (VBN approved) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT the) (JJ institutional) (NN committee)) (PP (IN for) (NP (NN animal) (NN use))))))) (. .)) )
( (HEADING (NP (NML (NML (NP (NNP Peyer) (POS 's)) (NNS patches)) (CC and) (NML (VBN isolated) (JJ lymphoid) (NN follicle))) (NNS numbers))) )
( (S (S (NP-SBJ-1 (DT The) (JJ entire) (JJ small) (NNS intestines)) (VP (VBD were) (VP (VBN removed) (NP-1 (-NONE- *))))) (CC and) (S (NP-SBJ-2 (NP (DT the) (NN number)) (PP (IN of) (NP (NNS PPs)))) (VP (VBD was) (VP (VBN determinated) (NP-2 (-NONE- *)) (PP-MNR (IN by) (NP (JJ macroscopic) (NN observation))) (PP-TMP (IN except) (PP (IN at) (NP (NP (NN birth)) (SBAR (WHADVP-3 (WRB where)) (S (NP-SBJ-4 (NNS PPs)) (VP (VBD were) (ADJP-PRD (RB too) (JJ small) (S (NP-SBJ-4 (-NONE- *PRO*)) (VP (TO to) (VP (VB be) (VP (VBN seen) (NP-4 (-NONE- *)) (PP-MNR (IN by) (NP (DT the) (JJ naked) (NN eye)))))))) (ADVP-TMP-3 (-NONE- *T*))))))))))) (. .)) )
( (S (PP-TMP (IN At) (NP (NN birth))) (, ,) (NP-SBJ-2 (JJ small) (NNS intestines)) (VP (VBD were) (VP (VP (VBN fixed) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (NN formalin)))) (, ,) (VP (VBN stained) (NP-2 (-NONE- *)) (PP-MNR (IN with) (NP (NML (CD 0.5) (NN %)) (NN methylene) (JJ blue)))) (CC and) (VP (VBN decolorized) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (JJ fresh) (NML (CD 2) (NN %)) (JJ acetic) (NN acid)))))) (. .)) )
( (S (PP (IN For) (NP (NN LF) (NNS counts))) (, ,) (NP-SBJ-1 (JJ small) (NNS intestines)) (VP (VBD were) (VP (VP (VBN fixed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NN formalin)))) (CC and) (VP (VBN rolled) (NP-1 (-NONE- *)) (PRT (RP up)) (PP (IN into) (NP (DT a) (`` ‘) (NNP Swiss) (HYPH -) (NN roll)))) ('' ’) (, ,) (VP (VBN embedded) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NN paraffin) (NNS blocks)))) (CC and) (VP (VBD cut) (NP-1 (-NONE- *)) (PP (IN into) (NP (NML (CD 5) (NN µm)) (NNS sections)))))) (. .)) )
( (S (NP-SBJ-1 (NNS LFs)) (VP (VBD were) (VP (VBN counted) (NP-1 (-NONE- *)) (PP-MNR (IN in) (NP (DT a) (JJ blind) (NN fashion))) (PP (IN on) (NP (NP (CD two) (NNS sections)) (PP (IN per) (NP (NNS blocks))))) (PP-TMP (IN after) (NP (NML (NN haematoxylin) (HYPH -) (NN eosin)) (NN staining))))) (. .)) )
( (HEADING (NP (NP (NN Cell) (NN composition)) (PP (IN of) (NP (NP (NP (NNP Peyer) (POS 's)) (NNS Patches)) (CC and) (NP (NNS spleens)))))) )
( (S (NP-SBJ-1 (NP (NN Cell) (NNS suspensions)) (PP (IN from) (NP (NNS PPs)))) (VP (VBD were) (VP (VBN prepared) (NP-1 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG pressing) (NP (NP (DT the) (CD three) (JJS largest) (NNS PPs)) (PP (IN for) (NP (DT each) (NN mouse)))) (PP-MNR (IN with) (NP (DT a) (NML (CD 5) (NN ml)) (NN syringe) (NN piston)))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN preparation)) (VP (VBD was) (ADVP-TMP (RB then)) (VP (VBN incubated) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NML (NML (CD 100) (NN U)) (PP (SYM /) (NP (NN ml)))) (NN collagenase) (NN D) (PRN (-LRB- -LRB-) (NP (NP (NNP Roche)) (, ,) (NP-LOC (NNP Mannheim)) (, ,) (NP-LOC (NNP Germany))) (-RRB- -RRB-)))) (PP-TMP (IN for) (NP (CD 30) (NNS minutes))) (PP (IN at) (NP (CD 37) (NN °C))) (PP-LOC (IN in) (NP (NN DMEM) (NNS media))))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Cells)) (PP (IN from) (NP (NN spleen)))) (VP (VBD were) (VP (VBN isolated) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (DT the) (JJ same) (NN procedure)) (PP (IN with) (NP (NP (DT an) (JJ additional) (NN step)) (PP (IN of) (NP (NP (NNS erythrocytes) (NN lysis)) (-LRB- -LRB-) (NP (NN Gey's) (HYPH -) (NN solution))))))))))) (-RRB- -RRB-) (. .)) )
( (S (PP-TMP (IN After) (NP (NN centrifugation))) (, ,) (NP-SBJ-1 (NNS cells)) (VP (VBD were) (VP (VP (VBN re-suspended) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NN DMEM) (NNS media)))) (CC and) (VP (VBN submitted) (NP-1 (-NONE- *)) (PP (IN to) (NP (NP (NML (NN flow) (NN cytometry)) (NNS analyses)) (PP (IN on) (NP (DT a) (NN FACScalibur) (PRN (-LRB- -LRB-) (NP (NNP Becton) (HYPH -) (NNP Dickinson)) (-RRB- -RRB-))))))) (, ,) (CC and) (VP (VBN analyzed) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NN Cell) (NN Quest) (CD 3.3) (PRN (-LRB- -LRB-) (NP (NNP Becton) (NNP Dickinson)) (-RRB- -RRB-))))))) (. .)) )
( (S (S (NP-SBJ-1 (NP (NP (JJ Monoclonal) (NNS antibodies)) (VP (VBN used) (NP (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB stain) (NP (NN cell) (NNS suspensions))))))) (NP-2 (-NONE- *ICH*))) (VP (VBD were) (VP (VBN purchased) (NP-1 (-NONE- *)) (PP (IN from) (NP=3 (NN BD) (NNP Biosciences) (PRN (-LRB- -LRB-) (NP (NP (NNP Pharmingen) (NNP Heidelberg)) (, ,) (NP-LOC (NNP Germany))) (-RRB- -RRB-)))) (: :) (NP-2=4 (NP (NP (NN PE) (HYPH -) (NN Cy5) (HYPH -) (JJ anti-CD3)) (-LRB- -LRB-) (NP (NN 17A2))) (-RRB- -RRB-) (, ,) (NP (NP (NN PE) (HYPH -) (NN Cy7) (HYPH -) (JJ anti-CD3)) (-LRB- -LRB-) (NP (CD 145) (HYPH -) (NN 2C11))) (-RRB- -RRB-) (, ,) (NP (NP (NN PE) (HYPH -) (NN Cy5) (HYPH -) (JJ anti-CD4)) (-LRB- -LRB-) (NP (NN H129.19))) (-RRB- -RRB-) (, ,) (NP (NP (NN PE) (HYPH -) (JJ anti-CD4)) (-LRB- -LRB-) (NP (NN RM4))) (-RRB- -RRB-) (, ,) (NP (NP (NN FITC) (HYPH -) (JJ anti-CD8)) (-LRB- -LRB-) (NP (CD 53) (HYPH -) (CD 6.7))) (-RRB- -RRB-) (, ,) (NP (NP (NN PE) (HYPH -) (JJ anti-CD11c)) (-LRB- -LRB-) (NP (NN HL3))) (-RRB- -RRB-) (, ,) (NP (NN PE) (HYPH -) (JJ anti-CD25)) (, ,) (NP (NP (NN PE) (HYPH -) (NN anti-CD45R) (HYPH /) (NN B220)) (-LRB- -LRB-) (NP (NN RA3) (HYPH -) (NN 6B2))) (-RRB- -RRB-) (, ,) (NP (NP (NN FITC) (HYPH -) (JJ anti-CD45RB)) (-LRB- -LRB-) (NP (NN 16A))) (-RRB- -RRB-) (, ,) (NP (NN APC) (HYPH -) (NN anti-annexin) (NN V)))))) (CC and) (S (NP-SBJ=3 (NP (NN eBioscience)) (-LRB- -LRB-) (NP-LOC (NNP San) (NNP Diego)) (, ,) (NP-LOC (NNP CA))) (-RRB- -RRB-) (: :) (NP=4 (NP (NN APC) (HYPH -) (NN anti-Ly) (HYPH -) (NN 6G)) (-LRB- -LRB-) (NP (NN RB6) (HYPH -) (NN 8C5)))) (-RRB- -RRB-) (. .)) )
( (HEADING (NP (NN Immunohistochemistry))) )
( (S (NP-SBJ-1 (NN M) (NNS cells)) (VP (VBD were) (VP (VBN counted) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NN FAE))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT a) (NN fluorescence) (NN microscope)) (PP-TMP (IN after) (NP (NP (NN immunostaining)) (PP (IN of) (NP (NP (NP (NN PP) (NN cryostat) (NNS sections) (PRN (-LRB- -LRB-) (NP (CD 5) (NN µm)) (-RRB- -RRB-))) (PP (IN with) (NP (ADJP (JJ anti-Ulex) (NNP Europeaeus)) (NNS antibodies) (PRN (-LRB- -LRB-) (NP (NP (CD 1)) (PP (SYM /) (NP (CD 250)))) (, ,) (NP (CD 2) (NN h)) (-RRB- -RRB-)) (PRN (-LRB- -LRB-) (NP (NNP Sigma)) (, ,) (NP (NNP France)) (-RRB- -RRB-))))) (, ,) (VP (VBN revealed) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (ADJP (JJ anti-Ulex) (NNP Europeaus)) (NN agglutinin) (CD I) (PRN (-LRB- -LRB-) (NP (NP (CD 1)) (PP (SYM /) (NP (CD 500)))) (, ,) (NP (CD 30) (NN min)) (. .) (-RRB- -RRB-)) (PRN (-LRB- -LRB-) (NP (NN Vector) (NNS laboratories)) (-RRB- -RRB-))) (CC and) (NP (JJ anti-rabbit) (NN FITC) (NN conjugate) (PRN (-LRB- -LRB-) (NP (NP (CD 1)) (PP (SYM /) (NP (CD 80)))) (, ,) (NP (CD 30) (NN min.)) (-RRB- -RRB-)) (PRN (-LRB- -LRB-) (NP (NP (NNP Sigma)) (, ,) (NP-LOC (NNP France))) (-RRB- -RRB-)))))))))))))) (. .)) )
( (S (NP-SBJ-1 (NML (NN Caspase) (CD 3)) (NN immunostaining)) (VP (VBD was) (VP (VBN done) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NN rabbit) (JJ polyclonal) (NNS antibodies)) (PP (IN to) (NP (VBN Cleaved) (NN Caspase) (HYPH -) (CD 3))) (PRN (-LRB- -LRB-) (NP (NN Asp) (CD 175)) (, ,) (FRAG (NP (NN dilution)) (: :) (NP (NP (CD 1)) (PP (SYM /) (NP (CD 100))))) (-RRB- -RRB-)) (PRN (-LRB- -LRB-) (NP (NP (NN Cell) (NN Signaling) (NN Technology)) (, ,) (NP-ADV (NN Inc) (NN Ozyme)) (, ,) (NP-LOC (NN Beverly)) (, ,) (NP-LOC (NN MA)) (, ,) (NP-LOC (NN USA))) (-RRB- -RRB-)))))) (. .)) )
( (HEADING (NP (NN Cytokine) (NML (NML (NN Enzyme) (HYPH -) (VBN Linked) (JJ Immunosorbent) (NN Assay)) (-LRB- -LRB-) (NML (NN ELISA))) (-RRB- -RRB-))) )
( (S (S (NP-SBJ-1 (NP (NNS PPs) (, ,) (NN ileum) (CC and) (NN spleen)) (PP (IN from) (NP (NML (NN WT) (CC and) (NN KO)) (NNS mice)))) (VP (VBD were) (VP (VP (VBN removed) (NP-1 (-NONE- *))) (, ,) (VP (VBN washed) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (JJ cold) (NNS PBS))))))) (CC and) (S (NP-SBJ-2 (NP (DT the) (NN concentration)) (PP (IN of) (NP (NN protein)))) (VP (VBD was) (VP (VBN determined) (NP-2 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (JJ commercial) (NN kit) (PRN (-LRB- -LRB-) (NP (NP (NNP Biorad)) (, ,) (NP-LOC (NNP Marnes) (NNP la) (NNP Coquette)) (, ,) (NP-LOC (NNP France))) (-RRB- -RRB-)))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN TNFα)) (, ,) (NP (NN IFNγ)) (, ,) (NP (NN IL) (HYPH -) (CD 4)) (CC and) (NP (NN IL) (HYPH -) (NN 1β))) (VP (VBD were) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN ELISA) (NNS assays) (PRN (-LRB- -LRB-) (NP (NN BD) (NNS Biosciences)) (-RRB- -RRB-)))) (PP-MNR (VBG according) (PP (IN to) (NP (NP (DT the) (NN manufacturer) (POS 's)) (NNS instructions)))))) (. .)) )
( (S (NP-SBJ-1 (DT All) (JJ experimental) (NNS groups)) (VP (VBD were) (VP (VBN tested) (NP-1 (-NONE- *)) (PP-MNR (IN in) (NP (NNS duplicates))))) (. .)) )
( (HEADING (NP (NML (NNP Ussing) (NN chamber)) (NNS experiments))) )
( (S (NP-SBJ-1 (NP (NNS Biopsies)) (PP (IN from) (NP (NN ileum))) (PP (IN with) (CC or) (IN without) (NP (NNS PPs)))) (VP (VBD were) (VP (VBN placed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT a) (NN chamber)) (VP (VBG exposing) (NP (NP (CD 0.196) (NN cm2)) (PP (IN of) (NP (NN tissue) (NN surface)))) (PP (IN to) (NP (NP (CD 1.5) (NN ml)) (PP (IN of) (NP (NP (VBG circulating) (VBN oxygenated) (NN Ringer) (NN solution)) (PP (IN at) (NP (CD 37) (NN °C)))))))))))) (. .)) )
( (S (NP-SBJ-1 (NML (NNS PP) (CC and) (NN ileum)) (NN permeability)) (VP (VBD were) (VP (VBN assessed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG measuring) (NP (NP (ADJP (JJ steady) (HYPH -) (NN state) (PRN (-LRB- -LRB-) (NP (QP (IN from) (CD 1) (IN to) (CD 2)) (NN h)) (-RRB- -RRB-))) (ADJP (ADJP (JJ mucosal)) (HYPH -) (PP (IN to) (HYPH -) (ADJP (JJ serosal)))) (NN flux)) (PP (IN of) (NP (NML (CD 4) (NN kDa)) (NN FITC) (HYPH -) (NN dextran) (PRN (-LRB- -LRB-) (NP (NP (NNP Sigma)) (, ,) (NP-LOC (NNP St.) (NNP Quentin) (NNP Fallavier)) (, ,) (NP-LOC (NNP France))) (-RRB- -RRB-)))))))))) (. .)) )
( (S (NP-SBJ-1 (JJ Bacterial) (NN translocation)) (VP (VBD was) (VP (VBN studied) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (NP (ADJP (RB chemically) (VBN killed)) (ADJP (NN fluorescein) (HYPH -) (VBN conjugated)) (NNP Escherichia) (NNP coli)) (NP (NN K) (HYPH -) (CD 12))) (CC or) (NP (NNP Staphylococcus) (NNP Aureus) (NNPS BioParticles) (PRN (-LRB- -LRB-) (NP (NP (NNP Molecular) (NNP Probes)) (, ,) (NP-LOC (NNP Leiden)) (, ,) (NP-LOC (DT the) (NNP Netherlands))) (-RRB- -RRB-))) (CC or) (NP (NP (DT a) (JJ viable) (NNP Escherichia) (NNP coli)) (-LRB- -LRB-) (NP (NP (DT the) (NN J53) (NN strain)) (ADJP (JJ resistant) (PP (IN to) (NP (NN rifampicin))))))) (-RRB- -RRB-) (PP (IN at) (NP (NP (DT a) (JJ final) (NN concentration)) (PP (IN of) (NP (NP (CD 1.107) (NN CFU)) (PP (SYM /) (NP (NN ml))))) (PP-LOC (IN in) (NP (DT the) (JJ mucosal) (NN reservoir))))))))) (. .)) )
( (S (NP-SBJ-1 (NML (NNP Saccharomyces) (NNP cerevisiae)) (NN translocation)) (VP (VBD was) (VP (VBN studied) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (ADJP (RB chemically) (VBN killed)) (ADJP (NN fluorescein) (HYPH -) (VBN conjugated)) (NML (NNP S.) (NNP cerevisiae)) (NNP BioParticles) (PRN (-LRB- -LRB-) (NP (NP (NNP Molecular) (NNP Probes)) (, ,) (NP-LOC (NNP Leiden)) (, ,) (NP-LOC (DT the) (NNP Netherlands))) (-RRB- -RRB-))) (PP (IN at) (NP (NP (DT a) (JJ final) (NN concentration)) (PP (IN of) (NP (NP (CD 1.107) (NN CFU)) (PP (SYM /) (NP (NN ml))))))) (PP-LOC (IN in) (NP (DT the) (JJ mucosal) (NN reservoir))))))) (. .)) )
( (HEADING (NP (JJ Real) (NN time) (NML (NML (JJ reverse) (NN transcription) (HYPH -) (NN polymerase) (NN chain) (NN reaction)) (-LRB- -LRB-) (NML (NN RT) (HYPH -) (NN PCR))) (-RRB- -RRB-))) )
( (S (PP-TMP (IN After) (NP (NP (NN extraction)) (PP (IN from) (NP (NP (NN PP)) (PP (IN of) (NP (NN ileum))))) (PP (IN by) (NP (DT the) (NNP NucleoSpin®) (NN RNA) (CD II) (NN Kit))) (PRN (-LRB- -LRB-) (NP (NP (NNP Macherey) (HYPH -) (NNP Nagel)) (, ,) (NP-LOC (NNP Hoerdt)) (, ,) (NP-LOC (NNP France))) (-RRB- -RRB-)))) (, ,) (NP-SBJ-1 (JJ total) (NN RNA)) (VP (VBD was) (VP (VP (VBN converted) (NP-1 (-NONE- *)) (PP (IN to) (NP (NN cDNA))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (JJ random) (NNS hexonucleotides))))) (CC and) (VP (ADVP-TMP (RB then)) (VBN used) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NN PCR)))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBD conducted) (NP (NN PCR)) (PP-MNR (IN with) (NP (NNP QuantiTect) (NN SYBR) (JJ Green) (NN PCR) (NN Kit) (PRN (-LRB- -LRB-) (NP (NP (NNP Applied)) (, ,) (NP-LOC (NNP Courtaboeuf)) (, ,) (NP-LOC (NNP France))) (-RRB- -RRB-)))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (NML (NN sense) (CC and) (JJ antisense)) (NNS primers)) (ADJP (JJ specific) (PP (IN for) (: :) (NP (NP (NP (NN G3PDH)) (, ,) (NP (NP (NML (CD 5) (SYM ′)) (HYPH -) (NN CACCATCTTCCAGGAGCGAG) (HYPH -) (CD 3) (SYM ′)) (CC and) (NP (NML (CD 5) (SYM ′)) (HYPH -) (NN GCCTTCTCCATGGTGGTGAA) (HYPH -) (CD 3) (SYM ′)))) (: ;) (NP (NP (NP (NN Occludin)) (-LRB- -LRB-) (NP (NN Occ))) (-RRB- -RRB-) (, ,) (NP (NP (NML (CD 5) (SYM ′)) (HYPH -) (NN AGCCTTCTGCTTCATCGCTTC) (HYPH -) (CD 3) (SYM ′)) (CC and) (NP (NML (CD 5) (SYM ′)) (HYPH -) (NN GTGGCAATAAACACCATGATGC) (HYPH -) (CD 3) (SYM ′)))) (: ;) (NP (NP (NP (NN Zonula) (NN Occludens) (HYPH -) (CD 1)) (-LRB- -LRB-) (NP (NN ZO) (HYPH -) (CD 1))) (-RRB- -RRB-) (, ,) (NP (NP (NML (CD 5) (SYM ′)) (HYPH -) (NN GACTCCAGACAACATCCCGAA) (HYPH -) (CD 3) (SYM ′)) (CC and) (NP (NML (CD 5) (SYM ′)) (HYPH -) (NN AACGCTGGAAATAACCTCGTTC) (HYPH -) (CD 3) (SYM ′)))) (: ;) (NP (NP (NP (NN Zonula) (NN Occludens) (HYPH -) (CD 2)) (-LRB- -LRB-) (NP (NN ZO) (HYPH -) (CD 2))) (-RRB- -RRB-) (, ,) (NP (NP (NML (CD 5) (SYM ′)) (HYPH -) (NN CAGCCACAATCAACGTGAATTC) (HYPH -) (CD 3) (SYM ′)) (CC and) (NP (NML (CD 5) (SYM ′)) (HYPH -) (NN CTGTCCTTCAAGCTGCCAAAC) (HYPH -) (CD 3) (SYM ′))))))))))) (. .)) )
( (S (PP-TMP (IN After) (NP (NN amplification))) (, ,) (NP-SBJ (PRP we)) (VP (VBD determined) (NP (NP (DT the) (NN threshold) (NN cycle)) (-LRB- -LRB-) (NP (NN Ct))) (-RRB- -RRB-) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB obtain) (NP (NN expression) (NNS values)))))) (. .)) )
( (HEADING (NP (NP (JJ Bacterial) (NN content)) (PP (IN of) (NP (NN ileum))))) )
( (S (S (NP-SBJ-1 (DT The) (JJ entire) (NN ileum) (PRN (-LRB- -LRB-) (NP (CD 5) (NN cm)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN removed) (NP-1 (-NONE- *))))) (CC and) (S (NP-SBJ-2 (JJ ileal) (NN content)) (VP (VBD was) (VP (VBN collected) (NP-2 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (NP (CD 3) (NN mL)) (PP (IN of) (NP (JJ steril) (NN water) (PRN (-LRB- -LRB-) (NP (NP (NNP Biorad)) (, ,) (NP-LOC (NNP France))) (-RRB- -RRB-))))) (VP (VBN administered) (NP (-NONE- *)) (PP-MNR (IN with) (NP (DT a) (NN polypropylene) (NN syringe)))))))))) (. .)) )
( (S (S (ADVP-TMP (RB Then)) (, ,) (NP-SBJ-1 (JJ ileal) (NN content)) (VP (VBD was) (VP (VBN homogenized) (NP-1 (-NONE- *))))) (CC and) (S (NP-SBJ-2 (NP (JJ serial) (NN dilution) (PRN (-LRB- -LRB-) (NP (CD 50) (NN µL)) (-RRB- -RRB-))) (PP (IN of) (NP (DT each) (NN aliquot)))) (VP (VBD were) (VP (VBN plated) (NP-2 (-NONE- *)) (PP-LOC (IN onto) (NP (CD 5) (JJ selective) (NN gelose) (PRN (-LRB- -LRB-) (NP (NN URI) (CD 4)) (, ,) (NP (NNP Drigalski)) (, ,) (NP (NNP Columbia)) (NP (NN ANC)) (SYM +) (NP (NP (CD 5) (NN %)) (PP (IN of) (NP (NP (NN sheep) (NN blood)) (, ,) (NP-ADV (NNP Chapman) (CC and) (NNP Coccosel))))) (-RRB- -RRB-))))))) (. .)) )
( (S (S (NP-SBJ-1 (NNS Plates)) (VP (VBD were) (VP (VBN incubated) (NP-1 (-NONE- *)) (PP-TMP (IN for) (NP (CD 24) (NNS hours))) (PP (IN at) (NP (CD 37) (NN °C))) (PP (IN under) (NP (JJ aerobic) (NN condition)))))) (CC and) (S (NP-SBJ-2 (NP (DT the) (NN number)) (PP (IN of) (NP (ADJP (NN colony) (VBG forming)) (NNS units)))) (VP (VBD was) (VP (VP (VBN counted) (NP-2 (-NONE- *))) (CC and) (VP (VBN expressed) (NP-2 (-NONE- *)) (PP (IN as) (NP (NP (NN cfu)) (PP (SYM /) (NP (NP (NN mg)) (PP (IN of) (NP (JJ ileal) (NN content))))))))))) (. .)) )
( (HEADING (NP (ADJP (NN TNBS) (VBN induced)) (NN colitis))) )
( (S (PP (IN Under) (NP (NN anaesthesia))) (NP-SBJ-1 (NN colitis)) (VP (VBD was) (VP (VBN induced) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (ADJP (NP (CD 12) (NN week)) (JJ old)) (NNS mice))) (PP (IN by) (NP-LGS (NP (DT a) (JJ single) (JJ intracolonic) (NN administration)) (PP (IN of) (NP (NP (NML (NML (CD 120) (NN mg)) (PP (SYM /) (NP (NN kg)))) (NN TNBS) (PRN (-LRB- -LRB-) (NP (NNP Sigma)) (, ,) (NP (NNP France)) (-RRB- -RRB-))) (VP (VBN dissolved) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NML (CD 50) (NN %)) (NN ethanol)))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT A) (NML (CD 50) (NN µl)) (NN aliquot)) (PP (IN of) (NP (DT the) (ADJP (RB freshly) (VBN prepared)) (NN solution)))) (VP (VBD was) (VP (VBN injected) (NP-1 (-NONE- *)) (PP (IN into) (NP (DT the) (NN colon))) (, ,) (NP-LOC (NP (CD 4) (NN cm)) (PP (IN from) (NP (DT the) (NN anus)))) (, ,) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT a) (NML (CD 3.5) (NN F)) (NN polyethylene) (NN catheter)))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NNS mice)) (VP (VBD were) (VP (VBN weighed) (CC and) (VBN killed) (NP-1 (-NONE- *)) (PP-TMP (NP-ADV (CD 72) (NN h)) (IN after) (NP (NN TNBS) (NN administration))))) (. .)) )
( (S (ADVP-TMP (RB Then)) (, ,) (NP-SBJ-1 (NP (NN body) (NN weight)) (, ,) (NP (NP (JJ macroscopic) (NN damage) (NN score)) (PP (VBG according) (NP (DT the) (NNP Wallace) (NNS scores))) (PRN (-LRB- [) (NP (CD 43)) (-RRB- ]))) (, ,) (CC and) (NP (NNS cytokines) (NNS levels))) (VP (VBD were) (VP (VBN assessed) (NP-1 (-NONE- *)))) (. .)) )
( (HEADING (NP (JJ Statistical) (NNS Analyses))) )
( (S (NP-SBJ-1 (NNS Values)) (VP (VBP are) (VP (VBN expressed) (NP-1 (-NONE- *)) (PP (IN as) (NP (NN mean) (SYM ±) (NN SEM))))) (. .)) )
( (S (NP-SBJ-1 (JJ Statistical) (NN analysis)) (VP (VBD were) (VP (VBN performed) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (NML (NNP GraphPad) (NNP Prism) (CD 4.00) (PRN (-LRB- -LRB-) (NP (NP (NNP GraphPad) (NNP Software)) (, ,) (NP-LOC (NNP San) (NNP Diego)) (, ,) (NP-LOC (NNP CA)) (, ,) (NP-LOC (NNP USA))) (-RRB- -RRB-))) (NN software) (NN package)) (PP (IN for) (NP (NN PC)))))))) (. .)) )
( (S (NP-SBJ-1 (JJ Single) (NNS comparisons)) (VP (VBD were) (VP (VBN performed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (JJ unpaired) (NP (NN Student) (POS 's)) (NN t) (HYPH -) (NN test))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT A) (NN value)) (PP (IN of) (S-TTL-FRM (NP-SBJ (NN P)) (VP (SYM <) (NP (CD 0.05)))))) (VP (VBD was) (VP (VBN considered) (NP-1 (-NONE- *)) (PP (IN as) (ADJP (RB statistically) (JJ significant))))) (. .)) )
( (S (NP-SBJ (DT All) (NN P) (NNS values)) (VP (VBD were) (ADJP-PRD (CD two) (VBN sided))) (. .)) )
( (HEADING (NP (JJ Supporting) (NN Information))) )
( (HEADING (NP (NN Table) (NN S1))) )
( (HEADING (NP (NP (NN Impact)) (PP (IN of) (NP (NN Nod2))) (PP (IN on) (NP (NP (NN body) (NN weight)) (, ,) (NP (NN gut) (NN weight)) (CC and) (NP (NN intestine) (NN length)))) (. .))) )
( (CAPTION (S (PP-TMP (IN At) (NP (NNS weeks) (NML (CD 4) (, ,) (CD 12) (CC and) (CD 52)))) (, ,) (NP-SBJ (PRP we)) (VP (VBD investigated) (NP (NP (NP (DT the) (NML (NN body) (CC and) (NN gut)) (NN weight)) (CC and) (NP (DT the) (NN intestine) (NN length))) (PP (IN of) (NP (NML (NN KO) (CC and) (NN WT)) (NNS mice))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (DT No) (NN difference)) (VP (VBD was) (VP (VBN observed) (NP-1 (-NONE- *)) (PP (IN between) (NP (NML (NN KO) (CC and) (NN WT)) (NNS mice))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN P)) (VP (SYM >) (NP (CD 0.05)))) (-RRB- -RRB-)))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Data)) (VP (VBP represent) (NP (NP (DT the) (NN means) (SYM ±) (NN SEM)) (PP (IN of) (NP (NP (CD 8) (NNS mice)) (PP (IN per) (NP (NN group))))))) (. .))) )
( (CAPTION (NP (-LRB- -LRB-) (NML (CD 0.03) (NN MB)) (NN TIF) (-RRB- -RRB-))) )
( (CAPTION (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB Click) (ADVP (RB here)) (PP (IN for) (NP (JJ additional) (NNS data) (NN file)))) (. .))) )
( (HEADING (NP (NN Table) (NN S2))) )
( (HEADING (NP (NP (JJ Ileal) (NN microflora)) (PP (IN under) (NP (JJ basal) (NN condition))) (. .))) )
( (CAPTION (S (PP (IN Under) (NP (JJ basal) (NN condition))) (, ,) (NP-SBJ-1 (DT no) (NN difference)) (VP (VBD was) (VP (VBN observed) (NP-1 (-NONE- *)) (PP (IN between) (NP (NML (NN KO) (CC and) (NN WT)) (NNS mice))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN P)) (VP (SYM >) (NP (CD 0.05)) (PP (IN for) (NP (DT each) (JJ bacterial) (NN group))))) (-RRB- -RRB-)))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Data)) (VP (VBP represent) (NP (NP (DT the) (NN means) (SYM ±) (NN SEM)) (PP (IN of) (NP (NP (CD 10) (NNS mice)) (PP (IN per) (NP (NN group))))))) (. .))) )
( (CAPTION (NP (-LRB- -LRB-) (NML (CD 0.03) (NN MB)) (NN TIF) (-RRB- -RRB-))) )
( (CAPTION (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB Click) (ADVP (RB here)) (PP (IN for) (NP (JJ additional) (NNS data) (NN file)))) (. .))) )
( (HEADING (NP (NN Figure) (NN S1))) )
( (HEADING (S (NP-SBJ (NP (NNS PPs)) (PP (IN from) (NP (NN KO) (NNS mice)))) (VP (VBP exhibit) (NP (NP (JJR higher) (NNS rates)) (PP (IN of) (NP (NP (NML (NN CD4) (SYM +)) (NML-1 (-NONE- *RNR*))) (CC and) (NP (NML (NN CD4) (HYPH -)) (NML (NN CD8) (HYPH -)) (NML-1 (-NONE- *RNR*)))) (NML-1 (NN T) (HYPH -) (NNS cells)))) (PP-TMP (IN at) (NP (NN week) (CD 4)))) (. .))) )
( (CAPTION (S (PP-TMP (IN At) (NP (NN week) (CD 4))) (, ,) (NP-SBJ-1 (NP (NML (NN CD3) (SYM +)) (NN T) (HYPH -) (NNS cells)) (VP (VBN recovered) (NP (-NONE- *)) (PP (IN from) (NP (NP (NNS PPs) (PRN (-LRB- -LRB-) (NP (NN A)) (-RRB- -RRB-))) (CC and) (NP (NN spleen) (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-))))))) (VP (VBD were) (VP (VBN stained) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (NNS antibodies)) (PP (IN to) (NP (NN CD3) (, ,) (NN CD4) (, ,) (CC and) (NN CD8))) (PP (IN from) (NP (NML (NML (NN KO) (PRN (-LRB- -LRB-) (NP (SYM ▪)) (-RRB- -RRB-))) (CC and) (NML (NN WT) (PRN (-LRB- -LRB-) (NP (SYM □)) (-RRB- -RRB-)))) (NNS mice))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NNS Data)) (VP (VBD were) (VP (VBN gated) (NP-1 (-NONE- *)) (PP (IN for) (NP (NML (NN CD3) (SYM +)) (NN T) (HYPH -) (NNS cells))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (JJ Relative) (NNS proportions)) (PP (IN of) (NP (CC both) (NP (NML (NN CD3) (SYM +)) (NML (NN CD4) (SYM +)) (NML-1 (-NONE- *RNR*))) (CC and) (NP (NML (NN CD3) (SYM +)) (NML (NN CD4) (SYM -)) (NML (NN CD8) (SYM -)) (NML-1 (-NONE- *T*))) (NML-1 (NN T) (HYPH -) (NNS cells))))) (VP (VBD were) (ADJP-PRD (RB significantly) (JJR higher)) (PP-LOC (PP (IN in) (NP (NP (DT the) (NNS PPs)) (PP-2 (-NONE- *RNR*)))) (CONJP (CC but) (RB not)) (PP (IN in) (NP (NP (DT the) (NN spleen) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN P)) (VP (SYM >) (NP (CD 0.05)))) (-RRB- -RRB-))) (PP-2 (-NONE- *RNR*)))) (PP-2 (IN of) (NP (NN KO) (NNS mice))))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Data)) (VP (VBP represent) (NP (NP (DT the) (NML (NN means) (SYM ±) (NN SEM))) (PP (IN of) (NP (NP (CD 8) (NNS mice)) (PP (IN per) (NP (NN group))))))) (. .))) )
( (CAPTION (S (S-FRM (NP-SBJ (NN *P)) (VP (SYM <) (NP (CD 0.05)))) (: ;) (S-FRM (NP-SBJ (NN **P)) (VP (SYM <) (NP (CD 0.01)))) (. .))) )
( (CAPTION (NP (-LRB- -LRB-) (NML (CD 0.08) (NN MB)) (NN TIF) (-RRB- -RRB-))) )
( (CAPTION (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB Click) (ADVP (RB here)) (PP (IN for) (NP (JJ additional) (NNS data) (NN file)))) (. .))) )
( (HEADING (NP (NN Figure) (NN S2))) )
( (HEADING (NP (NP (NML (NML (NN Nod2) (CC and) (NN CD3)) (SYM +)) (NN T) (HYPH -) (NNS cells)) (PP-LOC (IN in) (NP (NP (NNP Peyer) (POS 's)) (NNP Patches))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS A) (CC and) (LS B) (-RRB- -RRB-)) (NP (JJ Relative) (NNS proportions)) (PP (IN of) (NP (UCP (NN naïve) (, ,) (JJ regulatory) (CC and) (NN memory)) (NNS T) (HYPH -) (NNS cells))) (PP-LOC (IN in) (NP (NP (NP (NNS PPs) (PRN (-LRB- -LRB-) (NP (NN A)) (-RRB- -RRB-))) (CC and) (NP (NNS spleens) (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-)))) (PP (IN of) (NP (NML (NML (NN KO) (PRN (-LRB- -LRB-) (NP (SYM ▪)) (-RRB- -RRB-))) (CC and) (NML (NN WT) (PRN (-LRB- -LRB-) (NP (SYM □)) (-RRB- -RRB-)))) (NNS mice))))) (PP-TMP (IN at) (NP (NN week) (CD 12))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NML (NN CD4) (SYM +)) (NN T) (HYPH -) (NNS cells)) (VP (VBD were) (VP (VBN stained) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (NNS antibodies)) (PP (IN to) (NP (NN CD25) (CC and) (NN CD45RB))))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NP (JJ Relative) (NNS proportions)) (PP (IN of) (NP (NP (JJ apoptotic) (NML (NN CD3) (SYM +)) (NML-1 (-NONE- *RNR*))) (CC and) (NP (NML (NN CD3) (SYM +)) (NML (NN CD4) (SYM +)) (NML-1 (-NONE- *RNR*))) (NML-1 (NN T) (HYPH -) (NNS cells)))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (JJ Apoptotic) (NML (NN CD3) (SYM +)) (NML-2 (-NONE- *RNR*))) (CC and) (NP (NML (NN CD3) (SYM +)) (NML (NN CD4) (SYM +)) (NML-2 (-NONE- *RNR*))) (NML-2 (NN T) (HYPH -) (NNS cells))) (VP (VBD were) (VP (VBN investigated) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN flow) (NN cytometry))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (NNS antibodies)) (PP (IN to) (NP (NP (NN CD3)) (, ,) (NP (NN CD4)) (CC and) (NP (NN annexin) (CD V))))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NNS Data)) (VP (VBD were) (VP (VBN gated) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NML (NN CD3) (SYM +)) (NML (NN CD4) (SYM +)) (NN T) (HYPH -) (NNS cells))))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Data)) (VP (VBP represent) (NP (NP (DT the) (NML (NNS means) (SYM ±) (NN SEM))) (PP (IN of) (NP (NP (CD 8) (NNS mice)) (PP (IN per) (NP (NN group))))))) (. .))) )
( (CAPTION (NP (-LRB- -LRB-) (NML (CD 0.04) (NN MB)) (NN TIF) (-RRB- -RRB-))) )
( (CAPTION (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB Click) (ADVP (RB here)) (PP (IN for) (NP (JJ additional) (NNS data) (NN file))) (. .)))) )
( (HEADING (NP (NNS Acknowledgements))) )
( (S (NP-SBJ (PRP We)) (VP (VBP acknowledge) (NP (NP (NNP Veronique) (NNP Mégras)) (, ,) (NP (NNP Catherine) (NNP Martinet)) (, ,) (NP (NNP Michel) (NNP Peuchmaur)) (, ,) (NP (NNP Régine) (NNP Paris)) (, ,) (NP (NNP Pascal) (NNP Blain)) (, ,) (NP (NML (NNP Jean) (HYPH -) (NNP Baptiste)) (NNP Huguet)) (, ,) (NP (NNP Latifa) (NNP Ferkdadji)) (, ,) (NP (NNP Françoise) (NNP Merlin)) (, ,) (NP (NNP Robert) (NNP Ducroc)) (, ,) (NP (NNP Christèle) (NNP Madre)) (, ,) (NP (NNP Sarah) (NNP Cheriet)) (CC and) (NP (NNP Pauline) (NNP Thabuteau))) (PP-PRP (IN for) (NP (PRP$ their) (JJ excellent) (NN assistance)))) (. .)) )
( (HEADING (NP (NNS Figures) (CC and) (NNS Tables))) )
( (HEADING (NP (NN Figure) (CD 1))) )
( (HEADING (NP (NP (NP (NN Nod2)) (CC and) (NP (JJ postnatal) (NN development))) (PP (IN of) (NP (ADJP (NN gut) (VBN associated)) (JJ lymphoid) (NNS formations))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP (NNS PP) (NN count)) (PP (IN on) (NP (NP (DT the) (JJ whole) (NNS intestines)) (PP (IN of) (NP (NML (NML (NN KO) (PRN (-LRB- -LRB-) (NP (SYM ▪)) (-RRB- -RRB-))) (CC and) (NML (NN WT) (PRN (-LRB- -LRB-) (NP (SYM □)) (-RRB- -RRB-)))) (NNS mice))))) (PP-TMP (PP (IN at) (NP (NN birth))) (CC and) (PP (IN at) (NP (NNS weeks) (NML (CD 4) (, ,) (CD 12) (CC and) (CD 52))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP (NN Number)) (PP (IN of) (NP (NP (VBN isolated) (NNS LFs)) (VP (VBN identified) (NP (-NONE- *)) (PP-TMP (IN on) (NP (NP (JJ microscopic) (NN examination)) (PP (IN of) (NP (DT the) (JJ small) (NN intestine))) (PP-TMP (IN at) (NP (NNS weeks) (NML (CD 12) (CC and) (CD 52))))))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS C) (CC and) (LS D) (-RRB- -RRB-)) (NP (NN Number)) (PP (IN of) (NP (NP (NNS cells)) (PP (IN per) (NP (NN PP) (CC and) (NN spleen))))) (PP-TMP (IN at) (NP (NNS weeks) (NML (CD 4) (, ,) (CD 12) (CC and) (CD 52)))) (-RRB- -RRB-) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS E) (-RRB- -RRB-)) (NP (NN Number)) (PP (IN of) (NP (NP (JJ apoptotic) (NNS cells)) (VP (VBN identified) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NML (NN caspase) (HYPH -) (CD 3)) (NN immunostaining))) (PP-TMP (IN at) (NP (NN week) (CD 12)))))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Data)) (VP (VBP represent) (NP (NP (DT the) (NN means) (SYM ±) (NN SEM)) (PP (IN of) (NP (NP (CD 8) (NNS mice)) (PP (IN per) (NP (NN group))))))) (. .))) )
( (CAPTION (S (S-FRM (NP-SBJ (NN *P)) (VP (SYM <) (NP (CD 0.05)))) (: ;) (S-FRM (NP-SBJ (NN **P)) (VP (SYM <) (NP (CD 0.01)))) (, ,) (S-FRM (NP-SBJ (NN ***P)) (VP (SYM <) (NP (CD 0.001)))) (. .))) )
( (HEADING (NP (NN Figure) (CD 2))) )
( (HEADING (NP (NML (NML (NN Nod2)) (CC and) (NML (NP (NNP Peyer) (POS 's)) (NN patch))) (JJ cellular) (NN composition) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS A) (CC and) (LS B) (-RRB- -RRB-)) (NP (JJ Relative) (NNS proportions)) (PP (IN of) (NP (NP (UCP (NN T) (HYPH -) (, ,) (NN B) (HYPH -) (CC and) (JJ dendritic)) (NNS cells)) (PP (IN from) (NP (NP (NNS PPs) (CC and) (NNS spleens)) (PP (IN of) (NP (NML (NML (NN KO) (PRN (-LRB- -LRB-) (NP (SYM ▪)) (-RRB- -RRB-))) (CC and) (NML (NN WT) (PRN (-LRB- -LRB-) (NP (SYM □)) (-RRB- -RRB-)))) (NNS mice))))))) (PP-TMP (IN at) (NP (NN week) (CD 12))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (UCP (NN T) (HYPH -) (, ,) (NN B) (HYPH -) (CC and) (JJ dendritic)) (NNS cells)) (VP (VBD were) (VP (VBN investigated) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN flow) (NN cytometry))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (NNS antibodies)) (PP (IN to) (NP (NN CD3) (, ,) (NN B220) (CC and) (NN CD11c)))))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NP-SBJ-1 (NP (JJ Relative) (NN proportion)) (PP (IN of) (NP (JJ polymorphonuclear) (NNS neutrophils)))) (VP (VBD was) (VP (VBN analyzed) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NML (NN Ly) (HYPH -) (NN 6G)) (NN antibody)))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-)) (NP-SBJ-1 (NP (NML (NN M) (NNS cells)) (NN number)) (PP-LOC (IN inside) (NP (NP (DT the) (NN follicle)) (ADJP (VBN associated) (PP (IN with) (NP (NN epithelium))))))) (VP (VBD was) (VP (VBN investigated) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN immuno) (HYPH -) (NN histochemistry))))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Arrows)) (VP (VBD indicated) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN M) (HYPH -) (NN cell))) (PP-LOC (IN inside) (NP (NP (DT the) (NN follicle)) (ADJP (VBN associated) (PP (IN with) (NP (NN epithelium)))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Data)) (VP (VBP represent) (NP (NP (DT the) (NML (NN means) (SYM ±) (NN SEM))) (PP (IN of) (NP (NP (CD 8) (NNS mice)) (PP (IN per) (NP (NN group))))))) (. .))) )
( (CAPTION (S-FRM (NP-SBJ (NN **P)) (VP (SYM <) (NP (CD 0.01))) (. .))) )
( (HEADING (NP (NN Figure) (CD 3))) )
( (HEADING (NP (NP (NML (NML (NN Nod2)) (CC and) (NML (NNS T) (HYPH -) (NNS cells))) (NN subset)) (PP-LOC (IN in) (NP (NP (NNS PP) (CC and) (NN spleen)) (PP (IN from) (NP (NNS mice))))) (PP-TMP (IN at) (NP (NP (CD 12) (NNS weeks)) (PP (IN of) (NP (NN age))))) (. .))) )
( (CAPTION (NP (NP (JJ Relative) (NN proportion)) (PP (IN of) (NP (NP (NP (NML (NN CD4) (SYM +)) (, ,) (NML (NN CD8) (SYM +)) (NML-1 (-NONE- *RNR*))) (CC and) (NP (NML (NN CD4) (SYM −)) (NML (NN CD8) (SYM −)) (NML-1 (-NONE- *RNR*))) (NML-1 (NN T) (HYPH -) (NNS cells))) (PP (IN from) (NP (NP (NP (NNS PPs) (PRN (-LRB- -LRB-) (NP (NN A)) (-RRB- -RRB-))) (CC and) (NP (NN spleen) (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-)))) (PP (IN of) (NP (NML (NML (NN KO) (PRN (-LRB- -LRB-) (NP (SYM ▪)) (-RRB- -RRB-))) (CC and) (NML (NN WT) (PRN (-LRB- -LRB-) (NP (SYM □)) (-RRB- -RRB-)))) (NNS mice))))))) (. .))) )
( (CAPTION (S (PP-TMP (IN At) (NP (NN week) (CD 12))) (, ,) (NP-SBJ-1 (NML (NN CD3) (SYM +)) (NN T) (HYPH -) (NNS cells)) (VP (VBD were) (VP (VBN stained) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (NNS antibodies)) (PP (IN to) (NP (NN CD3) (, ,) (NN CD4) (, ,) (CC and) (NN CD8))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NNS Data)) (VP (VBD were) (VP (VBN gated) (NP-1 (-NONE- *)) (PP (IN for) (NP (NML (NN CD3) (SYM +)) (NN T) (HYPH -) (NNS cells))))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Data)) (VP (VBP represent) (NP (NP (DT the) (NML (NNS means) (SYM ±) (NN SEM))) (PP (IN of) (NP (NP (CD 8) (NNS mice)) (PP (IN per) (NP (NN group))))))) (. .))) )
( (CAPTION (S-FRM (NP-SBJ (NN *P)) (VP (SYM <) (NP (CD 0.05))) (. .))) )
( (HEADING (NP (NN Figure) (CD 4))) )
( (HEADING (S (NP-SBJ (NN Nod2) (NN invalidation)) (VP (VBZ increases) (NP (NN cytokine) (NN expression)) (PP-LOC (IN in) (NP (NNS PP)))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (NNS Expressions)) (PP (IN of) (NP (NP (NN Il) (HYPH -) (NN 1β)) (, ,) (NP (NN IFNγ)) (, ,) (NP (NN TNFα)) (, ,) (NP (NN IL) (HYPH -) (CD 12)) (, ,) (NP (NN IL) (HYPH -) (CD 4))))) (VP (VBD were) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN ELISA))) (PP-LOC (IN in) (NP (NP (NNS PPs) (, ,) (NN Ileum) (CC and) (NNS spleens)) (PP (IN from) (NP (NML (NML (NN KO) (PRN (-LRB- -LRB-) (NP (SYM ▪)) (-RRB- -RRB-))) (CC and) (NML (NN WT) (PRN (-LRB- -LRB-) (NP (SYM □)) (-RRB- -RRB-)))) (NNS mice))))) (PP-TMP (IN at) (NP (NNS weeks) (NML (NML (CD 4) (PRN (-LRB- -LRB-) (NP (JJ left) (NN panel)) (-RRB- -RRB-))) (CC and) (NML (CD 12) (PRN (-LRB- -LRB-) (NP (JJ right) (NN panel)) (-RRB- -RRB-)))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Data)) (VP (VBP represent) (NP (NP (DT the) (NML (NNS means) (SYM ±) (NN SEM))) (PP (IN of) (NP (NP (CD 8) (NNS mice)) (PP (IN per) (NP (NN group))))))) (. .))) )
( (CAPTION (S (S-FRM (NP-SBJ (NN *P)) (VP (SYM <) (NP (CD 0.05)))) (: ;) (S-FRM (NP-SBJ (NN **P)) (VP (SYM <) (NP (CD 0.01)))) (. .))) )
( (HEADING (NP (NN Figure) (CD 5))) )
( (HEADING (S (NP-SBJ-1 (NP (JJ Paracellular) (NN permeability)) (CC and) (NP (JJ bacterial) (NN translocation))) (VP (VBP are) (VP (VBN increased) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (ADJP (NN Nod2) (VBN invalidated)) (NNS mice))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NML (NML (NNP Ussing) (HYPH -) (NN chamber)) (CC and) (NML (NML (JJ Real) (HYPH -) (NN time)) (NN PCR))) (NNS experiments)) (VP (VBD were) (VP (VBN performed) (NP-1 (-NONE- *)) (PP (IN on) (NP (NP (NP (NNS PP)) (CC and) (NP (ADJP (NNS PP) (HYPH -) (JJ free)) (NN ileum))) (PP (IN from) (NP (NP (NN WT) (PRN (-LRB- -LRB-) (NP (SYM □)) (-RRB- -RRB-))) (CC and) (NP (NN KO) (PRN (-LRB- -LRB-) (NP (SYM ▪)) (-RRB- -RRB-))))))) (PP-TMP (IN at) (NP (NN week) (CD 12))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP-SBJ-1 (JJ Paracellular) (NN permeability)) (VP (VBD was) (VP (VBN analysed) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NML (NN FITC) (HYPH -) (NN dextran)) (NN flux)) (PP (IN from) (NP (NP (NNS PP)) (CC and) (NP (ADJP (NNS PP) (HYPH -) (JJ free)) (NN ileum)))))) (PP (IN under) (NP (JJ basal) (NN condition))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP-SBJ-1 (NP (NML (NN mRNA) (NN expression)) (NNS levels)) (PP (IN of) (NP (NP (NN TJ) (NN proteins)) (-LRB- -LRB-) (NP (NP (NN ZO) (HYPH -) (CD 1)) (, ,) (NP (NN ZO) (HYPH -) (CD 2)) (CC and) (NP (NN Occ))))) (-RRB- -RRB-) (PP (IN from) (NP (NN PP)))) (VP (VBD were) (VP (VBN analysed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NML (NN real) (HYPH -) (NN Time)) (HYPH -) (NN PCR))) (PP (IN under) (NP (JJ basal) (NN condition))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NP (JJ Bacterial) (NN translocation)) (PP (IN of) (NP (ADJP (RB chemically) (VBN killed)) (JJ fluorescent) (NML (NNP Escherichia) (NNP Coli)) (NN K) (HYPH -) (CD 12))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-)) (NP (NN Translocation)) (PP (IN of) (NP (DT the) (JJ viable) (ADJP (AFX non) (NN enteropathogen)) (NML (NNP Escherichia) (NNP Coli)) (NN strain) (NN J53))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS E) (-RRB- -RRB-)) (NP (NN Translocation)) (PP (IN of) (NP (DT a) (ADJP (RB chemically) (VBN killed)) (JJ fluorescent) (NNP Staphylococcus) (NNP Aureus))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS F) (-RRB- -RRB-)) (NP (NN Translocation)) (PP (IN of) (NP (ADJP (RB chemically) (VBN killed)) (ADJP (NN fluorescein) (HYPH -) (VBN conjugated)) (NNP Saccharomyces) (NNP cerevisiae))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Data)) (VP (VBP represent) (NP (NP (DT the) (NML (NN means) (SYM ±) (NN SEM))) (PP (IN of) (NP (NP (CD 8) (NNS mice)) (PP (IN per) (NP (NN group))))))) (. .))) )
( (CAPTION (S (S (S-FRM (NP-SBJ (NN *P)) (VP (SYM <) (NP (CD 0.05)))) (CC and) (S-FRM (NP-SBJ (NN **P)) (VP (SYM <) (NP (CD 0.01))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADJP-PRD (RB significantly) (JJ different) (PP (IN from) (NP (NN WT))))) (. .))) )
( (HEADING (NP (NN Figure) (CD 6))) )
( (HEADING (S (NP-SBJ (NN Nod2) (NN invalidation)) (VP (VBD increased) (NP (NP (DT the) (NN suceptibility)) (PP (IN of) (NP (ADJP (NN TNBS) (VBN induced)) (NN colitis))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (PRN (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NN Body) (NN weight)) (, ,) (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NML (JJ Macroscopic) (NN damage)) (NN score)) (, ,) (NP (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NNS cytokines) (NNS levels))) (VP (VBD were) (VP (VBN assessed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (ADJP (NP (CD 12) (NN week)) (JJ old)) (NNS mice))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (DT These) (NNS parameters)) (VP (VBD were) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-TMP (NP-ADV (CD three) (NNS days)) (IN after) (NP (NP (JJ intracolonic) (NN administration)) (PP (IN of) (NP (NN TNBS))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Values)) (VP (VBP are) (NP-PRD (NP (NN mean)) (-LRB- -LRB-) (NP (NN SEM))) (-RRB- -RRB-) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n )) (VP (SYM = ) (NP-PRD (CD 8)) (PP-LOC (IN in) (NP (DT each) (NN group))))) (-RRB- -RRB-))) (. .))) )
( (CAPTION (S (S-FRM (NP-SBJ (NN *P)) (VP (SYM <) (NP (CD 0.05)))) (CC and) (S-FRM (NP-SBJ (NN **P)) (VP (SYM <) (NP (CD 0.01)) (PP (IN between) (NP (NML (NN WT) (CC and) (NN KO)) (NNS mice))))) (. .))) )
( (HEADING (NP (NN Figure) (CD 7))) )
( (HEADING (NP (NP (NN Targeting) (NN disruption)) (PP (IN of) (NP (DT the) (JJ murine) (NN Nod2) (NN gene))) (PP (IN by) (NP (JJ homologous) (NN recombination))) (. .))) )
( (CAPTION (FRAG (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP (NN Generation)) (PP (IN of) (NP (DT the) (NML (NML (NN Card15) (HYPH /) (NN Nod2)) (NN KO)) (NN allele)))) (: :) (NP (NN targeting) (NN strategy)) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (DT The) (NN restriction) (NNS maps)) (PP (IN of) (NP (NP (DT the) (NML (NML (NN Card15) (HYPH /) (NN Nod2)) (SYM +)) (NN allele) (PRN (-LRB- -LRB-) (NP (NML (CD 5) (SYM ′)) (NN portion)) (-RRB- -RRB-))) (, ,) (NP (DT the) (NML (NML (NN Card15) (HYPH /) (NN Nod2)) (NN KO)) (VBG targeting) (NN fragment)) (, ,) (CC and) (NP (DT the) (VBN modified) (NML (NN Card15) (HYPH /) (NN Nod2)) (NN allele)))) (PP-TMP (IN after) (NP (NP (NP (JJ homologous) (NN recombination)) (CC and) (NP (ADJP (NN Cre) (HYPH -) (VBN mediated)) (NN recombination))) (PP (IN of) (NP (DT an) (NN Hygromycin) (NN selection) (NN cassette)))))) (VP (VBP are) (VP (VBN shown) (NP-1 (-NONE- *)))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (NNS Exons) (NML (CD 1) (, ,) (CD 2) (, ,) (CC and) (CD 3)) (PRN (-LRB- -LRB-) (NP (JJ black) (NNS boxes)) (-RRB- -RRB-))) (CC and) (NP (NP (NN restriction) (NNS sites)) (VP (VBN used) (NP (-NONE- *)) (PP-PRP (IN for) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG cloning) (CC and) (VBG screening) (NP (-LRB- -LRB-) (NP (NP (NN X)) (-RRB- -RRB-) (NP (NN XbaI))) (, ,) (-LRB- -LRB-) (NP (NP (NN A)) (-RRB- -RRB-) (NP (NN AgeI))) (, ,) (-LRB- -LRB-) (NP (NP (NN P)) (-RRB- -RRB-) (NP (NN PmlI))) (, ,) (-LRB- -LRB-) (NP (NP (NN S)) (-RRB- -RRB-) (NP (NN SalI))) (, ,) (-LRB- -LRB-) (NP (NP (NN N)) (-RRB- -RRB-) (NP (NN NotI)))))))))) (VP (VBP are) (VP (VBN indicated) (NP-1 (-NONE- *)))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (NML (NML (NN Card15) (HYPH /) (NN Nod2)) (NN KO)) (NN targeting) (NN fragment)) (VP (VBZ comprises) (NP (DT the) (NN EGFP) (NN gene) (PRN (-LRB- -LRB-) (NP (NNP Clontech)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NN frame)) (PP (IN with) (NP (NP (NP (NML (NN Card15) (HYPH /) (NN Nod2)) (NN ATG)) (CC and) (NP (DT the) (NML (VBN floxed) (NN PGKHygromycin) (PRN (-LRB- -LRB-) (NP (NNP Clontech)) (-RRB- -RRB-))) (NN selection) (NN cassette))) (, ,) (VP (VBN introduced) (NP (-NONE- *)) (PP (IN between) (NP (NP (NP (DT the) (NN AgeI) (NN site)) (ADVP-LOC (RB downstream) (PP (IN of) (NP (NML (NN Card15) (HYPH /) (NN Nod2)) (NN exon) (CD 1))))) (CC and) (NP (NP (DT the) (NN SalI) (NN site)) (RRC (ADJP-LOC-PRD (RB upstream) (PP (IN of) (NP (NN exon) (CD 1)))) (PP-LOC (IN in) (NP (DT the) (NML (NN Card15) (HYPH /) (NN Nod2)) (NN orientation))))))))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (DT All) (NN loxP) (NNS sites)) (VP (VBP are) (VP (VBN represented) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (JJ open) (NNS triangles))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (NN Recombination)) (PP (IN of) (NP (NN loxP1) (CC and) (NN loxP2)))) (VP (VBZ results) (PP (IN in) (NP (DT the) (NML (NN loxP1) (SYM +) (CD 2)) (NN site)))) (. .))) )
( (CAPTION (S (PP (IN In) (NP (NP (DT the) (JJ first) (NN step)) (PP (IN of) (NP (DT the) (NN strategy))))) (, ,) (NP-SBJ-1 (DT the) (NML (NN Card15) (HYPH /) (NN Nod2)) (NN locus)) (VP (VBD was) (VP (VBN targeted) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (DT the) (NML (NML (NN Card15) (HYPH /) (NN Nod2)) (NN KO)) (VBG targeting) (NN fragment))))) (. .))) )
( (CAPTION (S (PP (IN In) (NP (DT the) (JJ second) (NN step))) (, ,) (NP-SBJ-1 (DT the) (NN PGKHygromycin) (NN selection) (NN cassette)) (VP (VBD was) (VP (VBN removed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN Cre) (NN recombinase))))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (ADJP (JJ double) (HYPH -) (VBN headed)) (NNS arrows)) (VP (VBP indicate) (NP (NP (DT the) (NN DNA) (NNS fragments)) (VP (VBG resulting) (PP (IN from) (NP (NP (NNS digestions)) (PP (IN with) (NP (NP (JJ different) (NNS enzymes)) (VP (VBN expected) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB hybridize) (PP (IN with) (NP (NNS probes) (NML (NN A) (, ,) (NN B) (CC or) (NN Hyg))))))))))))))) (. .))) )
( (CAPTION (SINV (VP-TPC-1 (ADVP (RB Also)) (VBN depicted) (NP-2 (-NONE- *))) (VP (VBP are) (VP-1 (-NONE- *T*))) (NP-SBJ-2 (NP (NNS combinations)) (PP (IN of) (NP (NP (NP (NN PCR) (NNS primers) (NN P1)) (PP (SYM -) (NP (CD 4)))) (SBAR (WHNP-3 (WDT that)) (S (NP-SBJ-3 (-NONE- *T*)) (VP (VBP detect) (NP (DT the) (JJ different) (NML (NN Card15) (HYPH /) (NN Nod2)) (NNS alleles)))))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP (NP (NML (NNP Southern) (NN blot)) (NN analysis)) (PP (IN of) (NP (NP (VBN restricted) (NN DNA)) (VP (VBG resulting) (PP (IN from) (NP (NP (NN digestion)) (PP (IN with) (NP (NN XbaI))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (NN Hybridation)) (PP (IN with) (NP (NN Probe) (NML (NN A) (CC and) (NN B))))) (VP (VBP show) (NP (NP (JJ complete) (NN integration)) (PP (IN of) (NP (DT the) (VBG targetting) (NN fragment))) (PP-TMP (IN after) (NP (JJ homologous) (NN recombination))))) (. .))) )
( (CAPTION (S (NP-SBJ (NN Probe) (NN Hyg)) (VP (VBP show) (NP (NP (DT the) (NNS differents) (NNS integrations)) (PP (IN of) (NP (VBG targetting) (NNS fragments))) (PP-TMP (IN after) (NP (JJ homologous) (NN recombination))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NP (NN Genotyping)) (PP (IN of) (NP (ADJP (NN Nod2) (HYPH -) (JJ deficient)) (NNS mice))) (PP (IN by) (NP (NN PCR))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (JJ Genomic) (NN DNA)) (PP (IN from) (NP (NNS mice)))) (VP (VBD was) (VP (VBN amplified) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN PCR))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB detect) (NP (NP (DT the) (VBN disrupted) (NN sequence)) (-LRB- -LRB-) (NP (NP (NN PCR) (NN product)) (PP (IN of) (NP (CD 459) (NN bp)))))))))) (-RRB- -RRB-) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-)) (NP (NN Expression)) (PP (IN of) (NP (NN Nod2) (NN mRNA))) (PP-LOC (IN in) (NP (NN spleen))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NN RT) (HYPH -) (NN PCR)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (PP (IN on) (NP (NP (VBN purified) (NN mRNA)) (PP (IN from) (NP (NP (DT the) (NN spleen)) (PP (IN of) (NP (NML (NN WT) (CC and) (NN KO)) (NNS mice))))))))) (. .))) )
( (CAPTION (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN expected) (NP-1 (-NONE- *))))) (, ,) (NP-SBJ-2 (DT no) (NN signal)) (VP (VBD was) (VP (VBN observed) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (NN KO) (NNS mice))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NN GAPDH) (NN expression)) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)) (PP (IN as) (NP (NP (JJ positive) (NN control)) (PP (IN of) (NP (NN expression))))))) (. .))) )
( (HEADING (NP (NNS Footnotes))) )
( (FRAG (NP (VBG Competing) (NNS Interests)) (: :) (S (NP-SBJ (DT The) (NNS authors)) (VP (VBP have) (VP (VBN declared) (SBAR (IN that) (S (NP-SBJ (DT no) (VBG competing) (NNS interests)) (VP (VBP exist))))))) (. .)) )
( (FRAG (NP (NN Funding)) (: :) (S (NP-SBJ-1 (DT This) (NN work)) (VP (VBD was) (VP (VBN supported) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NNP the) (NNP Institut) (NNP National) (NNP de) (NNP la) (NNP Santé) (NNP et) (NNP de) (NNP la) (NNP Recherche) (NNP Médicale)) (, ,) (NP (NNP the) (NNP Broad) (NNP Medical) (NNP Research) (NNP Program)) (, ,) (NP (NNP la) (NNP Mairie) (NNP de) (NNP Paris)) (, ,) (NP (NNP la) (NNP Fondation) (NNP pour) (NNP la) (NNP Recherche) (NNP Médicale)) (, ,) (NP (NNP BREMICI)) (, ,) (NP (NN l'association) (NNP François) (NNP Aupetit)) (CC and) (NP (NNP la) (NNP région) (NNP Ile) (NNP de) (NNP France))))))) (. .)) )
